id,conversation_id,created_at,date,time,timezone,user_id,username,name,place,tweet,language,mentions,urls,photos,replies_count,retweets_count,likes_count,hashtags,cashtags,link,retweet,quote_url,video,thumbnail,near,geo,source,user_rt_id,user_rt,retweet_id,reply_to,retweet_date,translate,trans_src,trans_dest
1209444862522580998,1209444862522580998,2019-12-24 17:35:00 IST,2019-12-24,17:35:00,+0530,28436760,amgen,Amgen,,"Meet Alper Ureten, General Manager of #Amgen's Biosimilars Business Unit. We talked to him about the #biosimilars marketplace and how it will continue to evolve in 2020 and beyond. $AMGN",en,[],[],[],2,19,55,"['amgen', 'biosimilars']",['amgn'],https://twitter.com/Amgen/status/1209444862522580998,False,,0,,,,,,,,[],,,,
1207802394492461056,1207802394492461056,2019-12-20 04:48:25 IST,2019-12-20,04:48:25,+0530,525338789,davidgalanbolsa,David Gal√°n üìà,,"#Amgen $AMGN Muy fuerte, muy alcista y en subida libre, sin resistencias. Apunta a continuidad Tiene objetivo por ruptura del canal alcista al alza hacia los 264,48$. Gr√°fico similar al que ten√≠a Nestl√© hace 9 meses  https://t.co/XdUbzysIVs  https://t.co/73rw2l7mR2",es,[],['https://twitter.com/DavidGalanBolsa/status/1103771282804535304'],['https://pbs.twimg.com/media/EML532kUEAAhEaQ.jpg'],1,2,21,['amgen'],['amgn'],https://twitter.com/DavidGalanBolsa/status/1207802394492461056,False,https://twitter.com/DavidGalanBolsa/status/1103771282804535304,1,https://pbs.twimg.com/media/EML532kUEAAhEaQ.jpg,,,,,,,[],,,,
1207153758548955136,1197200783814594560,2019-12-18 09:50:58 IST,2019-12-18,09:50:58,+0530,906328017986899968,the_chart_life,"Ian McMillan, CMT",,$AMGN Amgen ...  https://t.co/U7FaMuRoYr,cy,[],[],['https://pbs.twimg.com/media/EMCroinXkAIjZnF.png'],1,1,14,[],['amgn'],https://twitter.com/the_chart_life/status/1207153758548955136,False,,1,https://pbs.twimg.com/media/EMCroinXkAIjZnF.png,,,,,,,[],,,,
1206557043676581888,1206557043676581888,2019-12-16 18:19:50 IST,2019-12-16,18:19:50,+0530,801116888,cfromhertz,Christian Fromhertz,,$AMGN *AMGEN ADDED TO GOLDMAN SACHS CONVICTION BUY LIST,en,[],[],[],0,3,8,[],['amgn'],https://twitter.com/cfromhertz/status/1206557043676581888,False,,0,,,,,,,,[],,,,
1205215721581686784,1205215721581686784,2019-12-13 01:29:54 IST,2019-12-13,01:29:54,+0530,857693619406467072,gualestrit,Gualestrit,,Nuevos m√°ximos hist√≥ricos hoy  Dow Jones S&amp;P 500 Nasdaq Nasdaq 100  Apple $AAPL Accenture $ACN Amgen $AMGN Broadcom $AVGO Best Buy $BBY Berkshire Hathaway $BRK.B Danaher $DHR Globe Life $GL Hilton $HLT JPMorgan $JPM Moody's $MCO Microsoft $MSFT Nike $NKE Thermo Fisher $TMO,und,[],[],[],2,28,57,[],"['aapl', 'acn', 'amgn', 'avgo', 'bby', 'brk.b', 'dhr', 'gl', 'hlt', 'jpm', 'mco', 'msft', 'nke', 'tmo']",https://twitter.com/gualestrit/status/1205215721581686784,False,,0,,,,,,,,[],,,,
1204880249948950528,1204880249948950528,2019-12-12 03:16:51 IST,2019-12-12,03:16:51,+0530,74841010,ejlandis,Eric Landis,,Another double-digit dividend increase for the portfolio! [] $AMGN - Amgen declares $1.60 dividend  https://t.co/nZsyZ88tOU,en,[],['https://seekingalpha.com/news/3525644-amgen-declares-1_60-dividend?source=tweet'],[],0,4,8,[],['amgn'],https://twitter.com/EJLandis/status/1204880249948950528,False,,0,,,,,,,,[],,,,
1204877081735311360,1204877081735311360,2019-12-12 03:04:16 IST,2019-12-12,03:04:16,+0530,2723696479,dividendhike,dividend hike,,#Amgen hikes dividend by 10 percent. $AMGN,en,[],[],[],0,4,22,['amgen'],['amgn'],https://twitter.com/dividendhike/status/1204877081735311360,False,,0,,,,,,,,[],,,,
1204869119461527552,1204869119461527552,2019-12-12 02:32:38 IST,2019-12-12,02:32:38,+0530,15079601,the_real_fly,The_Real_Fly,,Amgen increases quarterly dividend to $1.60/share from $1.45/share $AMGN,en,[],[],[],0,2,5,[],['amgn'],https://twitter.com/The_Real_Fly/status/1204869119461527552,False,,0,,,,,,,,[],,,,
1203339506243518464,1203339506243518464,2019-12-07 21:14:29 IST,2019-12-07,21:14:29,+0530,1111612082867372032,insiderbiotech,MM,,$PRNB They claimed 70K patients annually but there are only 2700 patients with ITP refractory. Btw $AMGN Amgen's Nplate for comparison (also for refractory ITP). And huge question on concomitant ITP medications used during the  trial üòâ  https://t.co/EJQbh5dRNz,en,[],[],"['https://pbs.twimg.com/media/ELMe5l4WsAYViA4.png', 'https://pbs.twimg.com/media/ELMe5mAXkAABFLj.png', 'https://pbs.twimg.com/media/ELMe5mBXUAAuaHL.png']",1,3,7,[],"['prnb', 'amgn']",https://twitter.com/InsiderBiotech/status/1203339506243518464,False,,1,https://pbs.twimg.com/media/ELMe5l4WsAYViA4.png,,,,,,,[],,,,
1202763296564117504,1202763296564117504,2019-12-06 07:04:50 IST,2019-12-06,07:04:50,+0530,865277757437001728,sonichedgefund,Sonic the Hedgefund,,"$AMGN $ARWR From LA Times archives. Interesting insight into how investors felt about Amgen in 1991, when it had a market cap of $3.7B (vs. current $138.7B mkt cap). Note, this was prior to Amgen being added to the S&amp;P 500, which occurred in early 1992.  https://t.co/HD7kq0muYN",en,[],['https://www.latimes.com/archives/la-xpm-1991-03-04-fi-135-story.html'],[],1,7,35,[],"['amgn', 'arwr']",https://twitter.com/sonichedgefund/status/1202763296564117504,False,,0,,,,,,,,[],,,,
1200516223173300224,1200516223173300224,2019-11-30 02:15:46 IST,2019-11-30,02:15:46,+0530,296994273,jwc54,John Cuozzo,,Nice animation Amgen!  Very cool representation of DEL. $AMGN #dnaencodedlibraries #drugdiscovery #DEL #chemistry  https://t.co/VTHAjUPRgA,en,[],['https://www.amgenscience.com/features/dna-encoded-libraries-will-drive-new-drug-design-paradigm/'],[],0,2,10,"['dnaencodedlibraries', 'drugdiscovery', 'del', 'chemistry']",['amgn'],https://twitter.com/jwc54/status/1200516223173300224,False,,0,,,,,,,,[],,,,
1198421416623955969,1198421416623955969,2019-11-24 07:31:45 IST,2019-11-24,07:31:45,+0530,102754598,johncendpts,John Carroll,,"Novartis is closing in on a $7B buyout of MedCo. And that may cause a restless weekend for Sanofi, Regeneron and Amgen $NVS $MDCO $SNY $AMGN  https://t.co/Xx0uknAAf9",en,[],['https://endpts.com/novartis-is-closing-in-on-a-7b-buyout-of-medco-and-that-may-cause-a-restless-weekend-for-sanofi-regeneron-and-amgen/'],[],3,6,31,[],"['nvs', 'mdco', 'sny', 'amgn']",https://twitter.com/JohnCendpts/status/1198421416623955969,False,,0,,,,,,,,[],,,,
1197871308123582464,1197871308123582464,2019-11-22 19:05:49 IST,2019-11-22,19:05:49,+0530,378334234,sarge986,Stephen Guilfoyle,,"News While You Slept, Semi Tough and Updates on Amgen and Splunk: Market Recon $TSLA $LRCX $AMAT $KLAC $AMD $XLK $AMGN $BMY $SPLK $FL $SJM  https://t.co/cFhoo6Ygr8 via @RealMoney",en,"[{'screen_name': 'realmoney', 'name': 'real money', 'id': '390812646'}]",['https://realmoney.thestreet.com/investing/stocks/news-while-you-slept-semi-tough-and-updates-on-amgen-and-splunk-market-recon-15178192'],[],4,6,8,[],"['tsla', 'lrcx', 'amat', 'klac', 'amd', 'xlk', 'amgn', 'bmy', 'splk', 'fl', 'sjm']",https://twitter.com/Sarge986/status/1197871308123582464,False,,0,,,,,,,,[],,,,
1197478448102428673,1197478448102428673,2019-11-21 17:04:44 IST,2019-11-21,17:04:44,+0530,28436760,amgen,Amgen,,"Amgen completed its acquisition of Otezla¬Æ(apremilast). ‚ÄúWe look forward to working with the dedicated professionals joining us from Celgene to help realize the global potential of Otezla as an important option for patients,‚Äù said CEO Bob Bradway.  https://t.co/u8af5wJfhT  $AMGN  https://t.co/nZrnjYppKM",en,[],['https://bit.ly/2QFoi4y'],['https://pbs.twimg.com/media/EJ2iU5jUcAAv-cO.jpg'],2,4,20,[],['amgn'],https://twitter.com/Amgen/status/1197478448102428673,False,,1,https://pbs.twimg.com/media/EJ2iU5jUcAAv-cO.jpg,,,,,,,[],,,,
1197476225918414848,1197476225918414848,2019-11-21 16:55:54 IST,2019-11-21,16:55:54,+0530,59393368,livesquawk,LiveSquawk,,Amgen Now Sees Yr Adj EPS: $14.5 To $14.7 (prev saw $14.2 To $14.45B) After Completes Purchase Of Otezla $AMGN,en,[],[],[],0,8,7,[],['amgn'],https://twitter.com/LiveSquawk/status/1197476225918414848,False,,0,,,,,,,,[],,,,
1197200783814594560,1197200783814594560,2019-11-20 22:41:24 IST,2019-11-20,22:41:24,+0530,906328017986899968,the_chart_life,"Ian McMillan, CMT",,"$AMGN Amgen ...""From tough markets come easy markets.""  https://t.co/QUUspYiqcA",en,[],[],['https://pbs.twimg.com/media/EJ1Pw6kX0AE6LNR.png'],1,0,30,[],['amgn'],https://twitter.com/the_chart_life/status/1197200783814594560,False,,1,https://pbs.twimg.com/media/EJ1Pw6kX0AE6LNR.png,,,,,,,[],,,,
1194244956266942464,1194244956266942464,2019-11-12 18:56:00 IST,2019-11-12,18:56:00,+0530,18294197,fiercebiotech,FierceBiotech,,"ICYMI: We announced 2019's Fiercest Women in Life Sciences yesterday! This year's list includes execs from @intelliatweets,  @bluebirdbio, @akerotx and @Amgen. #FierceWILS $NTLA $BLUE $AKRO $AMGN  https://t.co/tlL621AP7a",en,"[{'screen_name': 'intelliatweets', 'name': 'intellia therapeutics', 'id': '2696323176'}, {'screen_name': 'bluebirdbio', 'name': 'bluebird bio', 'id': '188882079'}, {'screen_name': 'akerotx', 'name': 'akerotx', 'id': '1009908560690601986'}, {'screen_name': 'amgen', 'name': 'amgen', 'id': '28436760'}]",['https://www.fiercepharma.com/special-report/2019-s-fiercest-women-life-sciences'],[],0,1,7,['fiercewils'],"['ntla', 'blue', 'akro', 'amgn']",https://twitter.com/FierceBiotech/status/1194244956266942464,False,,0,,,,,,,,[],,,,
1191415737635819521,1191415737635819521,2019-11-04 23:33:41 IST,2019-11-04,23:33:41,+0530,563084750,traderscom,Traders Community,,Biggest $SPX $NDX Stock Winners Last Week* KraftHeinz $KHC NXP Semiconductor $NXPI CTrip $CTRP Skyworks #SWKS Amgen $AMGN Buy in or take your profits?  https://t.co/ruq2Uux5zt  https://t.co/vqxEGxcDkX,en,[],['https://traderscommunity.com/index.php/market-talk/1807-market-weekly-november-3-9-2019'],['https://pbs.twimg.com/media/EIjCTHUXYAEdWkf.png'],0,5,6,['swks'],"['spx', 'ndx', 'khc', 'nxpi', 'ctrp', 'amgn']",https://twitter.com/TradersCom/status/1191415737635819521,False,,1,https://pbs.twimg.com/media/EIjCTHUXYAEdWkf.png,,,,,,,[],,,,
1191370631243321344,1191370631243321344,2019-11-04 20:34:27 IST,2019-11-04,20:34:27,+0530,857693619406467072,gualestrit,Gualestrit,,Nuevos m√°ximos hist√≥ricos   ‚ñ™Ô∏è Dow Jones ‚ñ™Ô∏è S&amp;P 500 ‚ñ™Ô∏è Nasdaq  ‚ñ™Ô∏è Apple $AAPL ‚ñ™Ô∏è Amgen $AMGN ‚ñ™Ô∏è Amtek $AME ‚ñ™Ô∏è Brookfield AM $BAM ‚ñ™Ô∏è CDW $CDW ‚ñ™Ô∏è Deere &amp; Co. $DE ‚ñ™Ô∏è Dover $DOV ‚ñ™Ô∏è JPMorgan $JPM ‚ñ™Ô∏è MSCI $MSCI ‚ñ™Ô∏è Qorvo $QRVO ‚ñ™Ô∏è Ferrari $RACE ‚ñ™Ô∏è Thermo Fisher $TMO ‚ñ™Ô∏è United Tech $UTX,pt,[],[],[],0,8,22,[],"['aapl', 'amgn', 'ame', 'bam', 'cdw', 'de', 'dov', 'jpm', 'msci', 'qrvo', 'race', 'tmo', 'utx']",https://twitter.com/gualestrit/status/1191370631243321344,False,,0,,,,,,,,[],,,,
1190339852182663169,1190339852182663169,2019-11-02 00:18:30 IST,2019-11-02,00:18:30,+0530,857693619406467072,gualestrit,Gualestrit,,Nuevos m√°ximos hist√≥ricos hoy  ‚ñ™Ô∏è S&amp;P 500 $SPX ‚ñ™Ô∏è Nasdaq $IXIC  ‚ñ™Ô∏è Apple $AAPL ‚ñ™Ô∏è Amgen $AMGN ‚ñ™Ô∏è AstraZeneca $AZN ‚ñ™Ô∏è Brookfield AM $BAM ‚ñ™Ô∏è Bio-Rad Labs $BIO ‚ñ™Ô∏è JPMorgan $JPM ‚ñ™Ô∏è Moody's $MCO ‚ñ™Ô∏è Morningstar $MORN ‚ñ™Ô∏è Sysco $SYY ‚ñ™Ô∏è United Tech $UTX ‚ñ™Ô∏è Vertex $VRTX,und,[],[],[],0,13,54,[],"['spx', 'ixic', 'aapl', 'amgn', 'azn', 'bam', 'bio', 'jpm', 'mco', 'morn', 'syy', 'utx', 'vrtx']",https://twitter.com/gualestrit/status/1190339852182663169,False,,0,,,,,,,,[],,,,
1189999206213271571,1189999206213271571,2019-11-01 01:44:54 IST,2019-11-01,01:44:54,+0530,274233761,bradloncar,Brad Loncar,,$BGNE $AMGN - This isn't just a China deal. BeiGene is helping Amgen develop these 20 drugs globally. It speaks to how BeiGene is establishing itself as global leader in oncology.,en,[],[],[],4,18,63,[],"['bgne', 'amgn']",https://twitter.com/bradloncar/status/1189999206213271571,False,,0,,,,,,,,[],,,,
1189997983456063488,1189997983456063488,2019-11-01 01:40:03 IST,2019-11-01,01:40:03,+0530,950942636818432006,syinvesting,SY Investing,,"$AMGN enters global strategic #oncology collaboration with $BGNE to expand China presence.  Amgen will take 20.5% stake in BeiGene for $2.7B cash at $174.85/ADS (36% premium to 30-day VWAP).  BeiGene to commercialize Xgeva, Kyprolis &amp; Blincyto in China.   https://t.co/Hnm2789A1w",en,[],['http://investors.amgen.com/news-releases/news-release-details/amgen-enters-strategic-collaboration-beigene-expand-oncology'],[],0,13,18,['oncology'],"['amgn', 'bgne']",https://twitter.com/syinvesting/status/1189997983456063488,False,,0,,,,,,,,[],,,,
1189997520153235456,1189997520153235456,2019-11-01 01:38:12 IST,2019-11-01,01:38:12,+0530,28436760,amgen,Amgen,,Amgen enters into strategic collaboration with BeiGene to expand oncology presence in China. Details here:  https://t.co/N8sgDOEBF0 $AMGN,en,[],['https://bit.ly/34k2DT0'],[],1,3,12,[],['amgn'],https://twitter.com/Amgen/status/1189997520153235456,False,,0,,,,,,,,[],,,,
1189996308213510144,1189996308213510144,2019-11-01 01:33:23 IST,2019-11-01,01:33:23,+0530,1705420616,btlipschultz,Bailey Lipschultz,,Amgen acquires a pretty massive stake in BeiGene for about $2.7 billion. More from @ArmstrongDrew on the terminal now. $AMGN $BGNE,en,"[{'screen_name': 'armstrongdrew', 'name': 'drew armstrong', 'id': '84684955'}]",[],[],1,2,2,[],"['amgn', 'bgne']",https://twitter.com/BTLipschultz/status/1189996308213510144,False,,0,,,,,,,,[],,,,
1189995847297257491,1189995847297257491,2019-11-01 01:31:33 IST,2019-11-01,01:31:33,+0530,102754598,johncendpts,John Carroll,,"Amgen takes a $2.7B stake in BeiGene, gaining a prominent ally in China to help seize a leading role in cancer drug commercialization and development $AMGN  https://t.co/uNZOAnQJvI",en,[],['https://endpts.com/amgen-takes-a-2-7b-stake-in-beigene-gaining-a-prominent-ally-in-china-to-help-seize-a-leading-role-in-cancer-drug-commercialization-and-development/'],[],0,9,29,[],['amgn'],https://twitter.com/JohnCendpts/status/1189995847297257491,False,,0,,,,,,,,[],,,,
1189995567193178112,1189995567193178112,2019-11-01 01:30:26 IST,2019-11-01,01:30:26,+0530,19717430,zbiotech,zach,,*AMGEN TO TAKE 20.5% STAKE IN BEIGENE WORTH $2.7 BILLION  $AMGN $BGNE,en,[],[],[],0,2,10,[],"['amgn', 'bgne']",https://twitter.com/zbiotech/status/1189995567193178112,False,,0,,,,,,,,[],,,,
1189515043118956545,1189515043118956545,2019-10-30 17:41:01 IST,2019-10-30,17:41:01,+0530,26368450,pearlf,Pearl Freier,,Amgen is the latest pharma to end their internal neuroscience R&amp;D  programs. Pfizer ended their internal programs  Jan '18. Congress &amp;  the Senate need to consider this- we need the US companies left to  continue working on neurodegenerative diseases $AMGN  https://t.co/COYJ5MdUiR,en,[],['http://bit.ly/2pgi7sp'],[],0,6,5,[],['amgn'],https://twitter.com/PearlF/status/1189515043118956545,False,,0,,,,,,,,[],,,,
1189494946824441856,1189494946824441856,2019-10-30 16:21:09 IST,2019-10-30,16:21:09,+0530,102754598,johncendpts,John Carroll,,Another one bites the dust: Amgen is joining the biopharma exodus out of neurosciences R&amp;D $AMGN $BIIB  https://t.co/a0rkZNfr0P,en,[],['https://endpts.com/amgen-is-joining-the-biopharma-exodus-out-of-neurosciences-rd/'],[],3,35,61,[],"['amgn', 'biib']",https://twitter.com/JohnCendpts/status/1189494946824441856,False,,0,,,,,,,,[],,,,
1189285786480447489,1189285786480447489,2019-10-30 02:30:02 IST,2019-10-30,02:30:02,+0530,913260122004086784,kessanman,Á±≥ÂõΩÊ†™ Ê±∫ÁÆó„Éû„É≥,,„Ç¢„É†„Ç∏„Çß„É≥Ê±∫ÁÆó Amgen (NASDAQ:AMGN) Q3'19 EPS(Non-GAAP) $3.66 ‰∫àÊÉ≥Ôºã$0.13 Â£≤‰∏ä $5.74B (-2.8% Y/Y) ‰∫àÊÉ≥Ôºã$110M  Á±≥„Éê„Ç§„Ç™ÂåªËñ¨ÂìÅÂ§ßÊâã„ÄÇ  Ê†™‰æ°„ÅØÊôÇÈñìÂ§ñ„Åß‰∏ÄÊôÇ+1.4%‰∏äÊòá„ÇÇÁèæÂú®„ÅØ„Éï„É©„ÉÉ„Éà  https://t.co/B7ZFa4ppT6  https://t.co/Bn55SJJEx7,ja,[],['http://investors.amgen.com/static-files/dcc87140-3b2f-49b3-aff4-73bc09608c0d'],"['https://pbs.twimg.com/media/EIExCfDU0AAimDA.png', 'https://pbs.twimg.com/media/EIExDS-U4AA3_It.png']",0,5,35,[],[],https://twitter.com/KessanMan/status/1189285786480447489,False,,1,https://pbs.twimg.com/media/EIExCfDU0AAimDA.png,,,,,,,[],,,,
1189272665363664896,1189272665363664896,2019-10-30 01:37:53 IST,2019-10-30,01:37:53,+0530,28436760,amgen,Amgen,,"As part of its Q3 earnings update, Amgen today announced that it raised guidance for the year, delivered its seventh straight quarter of volume-driven sales growth, and is advancing a record number of first-in-class molecules. $AMGN",en,[],[],[],0,2,14,[],['amgn'],https://twitter.com/Amgen/status/1189272665363664896,False,,0,,,,,,,,[],,,,
1189271321588441089,1189271321588441089,2019-10-30 01:32:33 IST,2019-10-30,01:32:33,+0530,15296897,marketcurrents,Breaking News,,"$AMGN - Amgen EPS beats by $0.13, beats on revenue  https://t.co/FnDWY9Exld",en,[],['https://seekingalpha.com/news/3510987-amgen-eps-beats-0_13-beats-revenue?source=feed_f&utm_campaign=twitter_automated&utm_content=news&utm_medium=social&utm_source=twitter'],[],0,2,5,[],['amgn'],https://twitter.com/MarketCurrents/status/1189271321588441089,False,,0,,,,,,,,[],,,,
1188832947270488064,1188832947270488064,2019-10-28 20:30:36 IST,2019-10-28,20:30:36,+0530,18639734,nasdaq,Nasdaq,,"With category-defining companies on the forefront of innovation‚Äî@Apple $APPL, @Microsoft $MSFT, @intel $INTC, @facebook $FB, @Amgen $AMGN, @Starbucks $SBUX, @Tesla $TSLA‚Äîthe Nasdaq-100 index defines today‚Äôs modern day industrials:  https://t.co/NfhSaCCQOW $NDX  https://t.co/bV0uXn6JXs",en,"[{'screen_name': 'apple', 'name': 'apple', 'id': '380749300'}, {'screen_name': 'microsoft', 'name': 'microsoft', 'id': '74286565'}, {'screen_name': 'intel', 'name': 'intel', 'id': '2803191'}, {'screen_name': 'facebook', 'name': 'facebook', 'id': '2425151'}, {'screen_name': 'amgen', 'name': 'amgen', 'id': '28436760'}, {'screen_name': 'starbucks', 'name': 'starbucks coffee', 'id': '30973'}, {'screen_name': 'tesla', 'name': 'tesla', 'id': '13298072'}]",['http://spr.ly/60181yFLK'],[],1,5,17,[],"['appl', 'msft', 'intc', 'fb', 'amgn', 'sbux', 'ndx']",https://twitter.com/Nasdaq/status/1188832947270488064,False,,1,https://pbs.twimg.com/media/EH-VQoGWoAAHNRh.jpg,,,,,,,[],,,,
1187360108566605824,1187360108566605824,2019-10-24 18:58:04 IST,2019-10-24,18:58:04,+0530,28436760,amgen,Amgen,,#Amgen will make Repatha (evolocumab) available exclusively at its lower list price effective 12/31/2019:  https://t.co/8coRjMtf4k $AMGN,en,[],['https://bit.ly/32JZawy'],[],0,2,10,['amgen'],['amgn'],https://twitter.com/Amgen/status/1187360108566605824,False,,0,,,,,,,,[],,,,
1187353350578331654,1187353350578331654,2019-10-24 18:31:13 IST,2019-10-24,18:31:13,+0530,19717430,zbiotech,zach,,"$AMGN  *AMGEN TO STOP SELLING HIGHER-PRICED VERSION OF CHOLESTEROL DRUG  *AMGEN TO PULL REPATHA THAT COSTS ABOUT $14,000/YEAR FROM MARKET  *AMGEN PLANS TO SELL ALL REPATHA FOR $5,850 STARTING DEC. 31",en,[],[],[],2,10,31,[],['amgn'],https://twitter.com/zbiotech/status/1187353350578331654,False,,0,,,,,,,,[],,,,
1186770008082223105,1186770008082223105,2019-10-23 03:53:13 IST,2019-10-23,03:53:13,+0530,223207812,truthtracer,truthtracer,,Likely a lot of new inquiries regarding $ARWR üëâüèªHere‚Äôs an excellent primer in case you missed Cramer‚Äôs 10/17/2019  Mad Money segment where Arrowhead CEO Chris Anzalone breaks down drug partnerships with $J&amp;J and Amgen $AMGN   https://t.co/9rQCm2W4dR,en,[],['https://www.cnbc.com/video/2019/10/17/arrowhead-ceo-breaks-down-drug-partnerships-with-jj-and-amgen.html'],[],0,0,14,[],"['arwr', 'j', 'amgn']",https://twitter.com/truthtracer/status/1186770008082223105,False,,0,,,,,,,,[],,,,
1178557062072209410,1178557062072209410,2019-09-30 11:57:54 IST,2019-09-30,11:57:54,+0530,1280320154,byamybrown,Amy Brown,,"Leerink: ""Amgen '510 Data Suggest Sub-optimal CRC Dosing, Opening Door for $MRTX to best""  Repeat after me: IT'S ALWAYS GOOD FOR MIRATI.   $AMGN",en,[],[],[],3,0,12,[],"['mrtx', 'amgn']",https://twitter.com/ByAmyBrown/status/1178557062072209410,False,,0,,,,,,,,[],,,,
1177893997886476289,1177893997886476289,2019-09-28 16:03:07 IST,2019-09-28,16:03:07,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Amgen‚Äôs KRAS-blocking drug shows minimal effect in colon cancer patients  https://t.co/VBPxScgymj  Good Saturday morning to you all. $AMGN $MRTX #ESMO19,en,[],['https://www.statnews.com/2019/09/28/amgens-kras-blocking-drug-shows-minimal-effect-in-colon-cancer-patients/'],[],4,15,46,['esmo19'],"['amgn', 'mrtx']",https://twitter.com/adamfeuerstein/status/1177893997886476289,False,,0,,,,,,,,[],,,,
1176957745628450816,1176957745628450816,2019-09-26 02:02:48 IST,2019-09-26,02:02:48,+0530,28436760,amgen,Amgen,,#Amgen will hold a webcast on Saturday to discuss the new data we will be sharing at #ESMO19. Details in the link below. $AMGN,en,[],[],[],0,5,6,"['amgen', 'esmo19']",['amgn'],https://twitter.com/Amgen/status/1176957745628450816,False,,0,,,,,,,,[],,,,
1170695577681780736,1170695577681780736,2019-09-08 19:19:10 IST,2019-09-08,19:19:10,+0530,102754598,johncendpts,John Carroll,,A stellar update on AMG510 stokes fresh enthusiasm on the future of Amgen's landmark KRAS G12C program $AMGN  https://t.co/LRNdvoSf7w,en,[],['https://endpts.com/a-stellar-update-on-amg510-stokes-fresh-enthusiasm-on-the-future-of-amgens-landmark-kras-g12c-program/'],[],1,13,30,[],['amgn'],https://twitter.com/JohnCendpts/status/1170695577681780736,False,,0,,,,,,,,[],,,,
1170635025076953088,1170635025076953088,2019-09-08 15:18:33 IST,2019-09-08,15:18:33,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Data on Amgen‚Äôs KRAS-blocking cancer drug are encouraging, but also raise new questions  https://t.co/ZxNOZSFf1h $AMGN #WCLC19",en,[],['https://www.statnews.com/2019/09/08/amgen-kras-hed-tk/'],[],1,13,26,['wclc19'],['amgn'],https://twitter.com/adamfeuerstein/status/1170635025076953088,False,,0,,,,,,,,[],,,,
1170626947724009472,1170626947724009472,2019-09-08 14:46:28 IST,2019-09-08,14:46:28,+0530,102094857,adamfeuerstein,Adam Feuerstein,,"Data on Amgen‚Äôs KRAS-blocking cancer drug are encouraging, but also raise new questions  https://t.co/ZxNOZSFf1h $AMGN",en,[],['https://www.statnews.com/2019/09/08/amgen-kras-hed-tk/'],[],1,3,9,[],['amgn'],https://twitter.com/adamfeuerstein/status/1170626947724009472,False,,0,,,,,,,,[],,,,
1167451239937957888,1167451239937957888,2019-08-30 20:27:20 IST,2019-08-30,20:27:20,+0530,1062074042969137152,the_ravid,The_Ravid,,"$AMGN so Amgen went from a rumored buyout of $ALXN to now challenging Soliris patents?  Just another blow to biotech, which continues to underperform relative to major indexes.",en,[],[],[],3,1,12,[],"['amgn', 'alxn']",https://twitter.com/The_Ravid/status/1167451239937957888,False,,0,,,,,,,,[],,,,
1167428201175404544,1167404369521852416,2019-08-30 18:55:47 IST,2019-08-30,18:55:47,+0530,1026340653209276417,markc53916729,Mark C,,"@BayAreaBiotechI $ARWR is the next $AMGN . ‚ÄúLonger term, we view Arrowhead as Amgen in the making for the greater Los Angeles area, to revolutionize RNAi technology, similar to how Amgen did with antibody technology.‚Äù ‚Äî Mayank Mamtani, analyst, B. Riley FBR Inc.",en,[],[],[],1,0,16,[],"['arwr', 'amgn']",https://twitter.com/MarkC53916729/status/1167428201175404544,False,,0,,,,,,,,"[{'screen_name': 'BayAreaBiotechI', 'name': 'BayAreaBiotechI', 'id': '57251718'}]",,,,
1167418498441732097,1167418498441732097,2019-08-30 18:17:14 IST,2019-08-30,18:17:14,+0530,19717430,zbiotech,zach,,*ALEXION PATENTS GET REVIEW ON AMGEN CHALLENGE AT PATENT OFFICE  *AMGEN IS CHALLENGING THREE ALEXION PATENTS FOR SOLIRIS DRUG  *U.S. PATENT OFFICE WILL ISSUE FINAL DECISION IN ABOUT A YEAR  $AMGN $ALXN,en,[],[],[],1,7,12,[],"['amgn', 'alxn']",https://twitter.com/zbiotech/status/1167418498441732097,False,,0,,,,,,,,[],,,,
1167100643569541127,1167100643569541127,2019-08-29 21:14:11 IST,2019-08-29,21:14:11,+0530,1280320154,byamybrown,Amy Brown,,"Amgen's aggressive legal pursuit of Sanofi and Regeneron's Praluent might work in the end, but will the PCSK9 developers ever recoup their costs? We dug into @evaluatepharma data to look at clinical trial costs.  https://t.co/GoS5gzvTRH $AMGN $SNY $REGN $MDCO  https://t.co/2bEDOo6fbp",en,"[{'screen_name': 'evaluatepharma', 'name': 'evaluate pharma', 'id': '43901066'}]",['https://www.evaluate.com/vantage/articles/data-insights/other-data/pcsk9-wars-continue-what-cost'],['https://pbs.twimg.com/media/EDJf2QBXUAIFcfO.png'],1,11,8,[],"['amgn', 'sny', 'regn', 'mdco']",https://twitter.com/ByAmyBrown/status/1167100643569541127,False,,1,https://pbs.twimg.com/media/EDJf2QBXUAIFcfO.png,,,,,,,[],,,,
1166788434574434304,1166788434574434304,2019-08-29 00:33:35 IST,2019-08-29,00:33:35,+0530,19717430,zbiotech,zach,,"*AMGEN PATENTS ON BLOCKBUSTER REPATHA DRUG INVALID, JUDGE RULES  $AMGN $REGN",en,[],[],[],4,18,19,[],"['amgn', 'regn']",https://twitter.com/zbiotech/status/1166788434574434304,False,,0,,,,,,,,[],,,,
1165947316152520704,1165947316152520704,2019-08-26 16:51:17 IST,2019-08-26,16:51:17,+0530,190773758,sports_bios,Sports_Bios,,"$AMGN did buy something, just not that ONE..   probably a good use of cash for Amgen..  deal price is on the higher side..  but whatever..",en,[],[],[],1,0,6,[],['amgn'],https://twitter.com/Sports_bios/status/1165947316152520704,False,,0,,,,,,,,[],,,,
1165944167329075201,1165944167329075201,2019-08-26 16:38:46 IST,2019-08-26,16:38:46,+0530,102754598,johncendpts,John Carroll,,BREAKING: Amgen swoops in with $13.4B deal to pluck blockbuster Otezla from Celgene $AMGN $CELG $BMY  https://t.co/HXmDDWjsgx,en,[],['https://endpts.com/breaking-amgen-swoops-in-with-13-4b-deal-to-pluck-blockbuster-otezla-from-celgene/'],[],0,6,12,[],"['amgn', 'celg', 'bmy']",https://twitter.com/JohnCendpts/status/1165944167329075201,False,,0,,,,,,,,[],,,,
1165935826200682496,1165935826200682496,2019-08-26 16:05:37 IST,2019-08-26,16:05:37,+0530,3426014292,semodough,dough,,"$AMGN To Acquire Otezla¬Æ For $13.4 Billion In Cash, Or Approximately $11.2 Billion Net Of Anticipated Future Cash Tax Benefits | Amgen Inc. $BMY $CELG   https://t.co/aZczHqzgJl",en,[],['http://investors.amgen.com/news-releases/news-release-details/amgen-acquire-otezlar-134-billion-cash-or-approximately-112/'],[],1,5,13,[],"['amgn', 'bmy', 'celg']",https://twitter.com/semodough/status/1165935826200682496,False,,0,,,,,,,,[],,,,
1165935825474871296,1165935825474871296,2019-08-26 16:05:37 IST,2019-08-26,16:05:37,+0530,28436760,amgen,Amgen,,"Amgen to acquire Otezla¬Æ (apremilast), the only oral, non-biologic treatment for #psoriasis &amp; psoriatic arthritis. This innovative therapy is a strategic fit with our long-standing expertise in psoriasis &amp; inflammation. PI:  https://t.co/z3NwgunE1i $AMGN #psoriasisawarenessmonth",en,[],['https://bit.ly/2E9aw4M'],[],5,22,37,"['psoriasis', 'psoriasisawarenessmonth']",['amgn'],https://twitter.com/Amgen/status/1165935825474871296,False,,0,,,,,,,,[],,,,
1165935159276974080,1165935159276974080,2019-08-26 16:02:58 IST,2019-08-26,16:02:58,+0530,2704294333,deitaone,*Walter Bloomberg,,AMGEN TO BUY OTEZLA FOR $13.4 BILLION IN CASH $AMGN,en,[],[],[],3,6,7,[],['amgn'],https://twitter.com/DeItaone/status/1165935159276974080,False,,0,,,,,,,,[],,,,
1164552253170233344,1164552253170233344,2019-08-22 20:27:48 IST,2019-08-22,20:27:48,+0530,19717430,zbiotech,zach,,"*AN AMGEN/ALEXION DEAL COULD BE HIGHLY ACCRETIVE, MIZUHO SAYS  $AMGN $ALXN  https://t.co/XSMd6wHObi",en,[],[],['https://pbs.twimg.com/tweet_video_thumb/EClSGHtXkAAazsq.jpg'],5,6,23,[],"['amgn', 'alxn']",https://twitter.com/zbiotech/status/1164552253170233344,False,,1,https://pbs.twimg.com/tweet_video_thumb/EClSGHtXkAAazsq.jpg,,,,,,,[],,,,
1161007089000431616,1161007089000431616,2019-08-13 01:40:35 IST,2019-08-13,01:40:35,+0530,97334517,allstarcharts,J.C. Parets,,you got stocks like Deutsche Bank and you have stocks like Amgen....it's a messy market $DB $AMGN,en,[],[],[],3,1,14,[],"['db', 'amgn']",https://twitter.com/allstarcharts/status/1161007089000431616,False,,0,,,,,,,,[],,,,
1160899008660955136,1160899008660955136,2019-08-12 18:31:06 IST,2019-08-12,18:31:06,+0530,16806253,arthurhill,"Arthur Hill, CMT",,"If a stock can hold its lows when others are breaking theirs and break out when others are falling short....we should pay attention. New 4min video highlighting Amgen. $SPY, $XLV, $XBI, $AMGN  https://t.co/y31KIIio7l",en,[],['https://youtu.be/XshaTVoNjOI'],[],0,1,11,[],"['spy', 'xlv', 'xbi', 'amgn']",https://twitter.com/ArthurHill/status/1160899008660955136,False,,0,,,,,,,,[],,,,
1160627906697138177,1160627906697138177,2019-08-12 00:33:51 IST,2019-08-12,00:33:51,+0530,61342056,optionshawk,Joe Kunkle,,Amgen $AMGN did some major work last week  https://t.co/uQ6nMxSeUB,en,[],[],['https://pbs.twimg.com/media/EBtg7RaXUAAn1ah.jpg'],1,2,8,[],['amgn'],https://twitter.com/OptionsHawk/status/1160627906697138177,False,,1,https://pbs.twimg.com/media/EBtg7RaXUAAn1ah.jpg,,,,,,,[],,,,
1159911420009619457,1159911420009619457,2019-08-10 01:06:47 IST,2019-08-10,01:06:47,+0530,801116888,cfromhertz,Christian Fromhertz,,$AMGN *AMGEN WINS RULING THAT UPHOLDS PATENTS FOR ENBREL DRUG,en,[],[],[],0,3,7,[],['amgn'],https://twitter.com/cfromhertz/status/1159911420009619457,False,,0,,,,,,,,[],,,,
1159911175112445952,1159911175112445952,2019-08-10 01:05:48 IST,2019-08-10,01:05:48,+0530,31546412,tradehawk,TradeHawk,,$AMGN Amgen wins Enbrel case vs Sandoz  https://t.co/8EkDBDJe2D,ht,[],[],['https://pbs.twimg.com/media/EBjVENPUIAA7E0m.jpg'],1,7,6,[],['amgn'],https://twitter.com/TradeHawk/status/1159911175112445952,False,,1,https://pbs.twimg.com/media/EBjVENPUIAA7E0m.jpg,,,,,,,[],,,,
1159426529018798081,1159426529018798081,2019-08-08 17:00:00 IST,2019-08-08,17:00:00,+0530,368158573,rebeccadrobbins,Rebecca Robbins,,.@Amgen's digital health VP told me that he and his team have discussed some 300 potential health-tech partners so far this year. My @statnews story on $AMGN's intense winnowing process:  https://t.co/5oVpXrtsxw,en,"[{'screen_name': 'amgen', 'name': 'amgen', 'id': '28436760'}, {'screen_name': 'statnews', 'name': 'stat', 'id': '3290364847'}]",['https://www.statnews.com/2019/08/08/health-tech-startups-intense-winnowing'],[],1,17,26,[],['amgn'],https://twitter.com/RebeccaDRobbins/status/1159426529018798081,False,,0,,,,,,,,[],,,,
1157840871460462593,1157840871460462593,2019-08-04 07:59:10 IST,2019-08-04,07:59:10,+0530,1026340653209276417,markc53916729,Mark C,,"‚ÄúLonger term, we view Arrowhead as Amgen in the making for the greater Los Angeles area, to revolutionize RNAi technology, similar to how $AMGN did with antibody technology.‚Äù ‚Äî Mayank Mamtani, analyst, B. Riley FBR Inc. $ARWR | Los Angeles Business Journal  https://t.co/QG839roYHQ",en,[],['http://www.labusinessjournal.com//news/2019/jul/19/arrowhead-pharmaceuticals-inc/'],[],4,5,27,[],"['amgn', 'arwr']",https://twitter.com/MarkC53916729/status/1157840871460462593,False,,0,,,,,,,,[],,,,
1156684714343723008,1156684714343723008,2019-08-01 03:25:00 IST,2019-08-01,03:25:00,+0530,865277757437001728,sonichedgefund,Sonic the Hedgefund,,$ARWR $AMGN More detail from Amgen cc re: AMG-890 (ie. ARO-LPA)  https://t.co/YD2HrcfYTz,cy,[],[],['https://pbs.twimg.com/media/EA1eIr5U0AEqrVq.jpg'],0,0,11,[],"['arwr', 'amgn']",https://twitter.com/sonichedgefund/status/1156684714343723008,False,,1,https://pbs.twimg.com/media/EA1eIr5U0AEqrVq.jpg,,,,,,,[],,,,
1156297544231559168,1156297544231559168,2019-07-31 01:46:32 IST,2019-07-31,01:46:32,+0530,865277757437001728,sonichedgefund,Sonic the Hedgefund,,$ARWR $AMGN from Amgen's presentation today re: AMG-890 (formerly ARO-LPA)  https://t.co/mnJ8FOZ6aK,en,[],[],['https://pbs.twimg.com/media/EAv-TMsUcAU7QgM.jpg'],0,2,31,[],"['arwr', 'amgn']",https://twitter.com/sonichedgefund/status/1156297544231559168,False,,1,https://pbs.twimg.com/media/EAv-TMsUcAU7QgM.jpg,,,,,,,[],,,,
1156296315610886144,1156296315610886144,2019-07-31 01:41:39 IST,2019-07-31,01:41:39,+0530,913260122004086784,kessanman,Á±≥ÂõΩÊ†™ Ê±∫ÁÆó„Éû„É≥,,„Ç¢„É†„Ç∏„Çß„É≥Ê±∫ÁÆó Amgen (NASDAQ:AMGN) Q2'19 EPS(Non-GAAP) $3.97 ‰∫àÊÉ≥ +$0.39 Â£≤‰∏ä $5.87B (-3.1% Y/Y) ‰∫àÊÉ≥ +$200M  „Éê„Ç§„Ç™ÂåªËñ¨ÂìÅÂ§ßÊâã„ÄÇÊ†™‰æ°„ÅØÊôÇÈñìÂ§ñ„Åß+1%  https://t.co/gyQ6UiQTbx  https://t.co/TICl9LLsn3,ja,[],['http://investors.amgen.com/static-files/e1393dc2-f372-4dcc-992a-afc36a03b8fa'],"['https://pbs.twimg.com/media/EAv9VKqVUAAaGuv.jpg', 'https://pbs.twimg.com/media/EAv9V2yUEAAjPfi.jpg', 'https://pbs.twimg.com/media/EAv9WgOUIAAG3D3.jpg', 'https://pbs.twimg.com/media/EAv9XMLVAAADLne.jpg']",0,7,16,[],[],https://twitter.com/KessanMan/status/1156296315610886144,False,,1,https://pbs.twimg.com/media/EAv9VKqVUAAaGuv.jpg,,,,,,,[],,,,
1150123396333785088,1150123396333785088,2019-07-14 00:52:40 IST,2019-07-14,00:52:40,+0530,401575573,dividendc2,dividendc2,,"MY TOP5 best companies bio      tec           hno                logy  1: Amgen Inc $AMGN   2: Vertex Pharmaceuticals Incorporated $VRTX  3: Illumina, Inc. $ILMN  4: Sarepta Therapeutics, Inc. $SRPT  5: Array Biopharma Inc $ARRY",en,[],[],[],2,4,10,[],"['amgn', 'vrtx', 'ilmn', 'srpt', 'arry']",https://twitter.com/dividendc2/status/1150123396333785088,False,,0,,,,,,,,[],,,,
1149308203076743169,1149308203076743169,2019-07-11 18:53:23 IST,2019-07-11,18:53:23,+0530,1026340653209276417,markc53916729,Mark C,,"@OTSociety  https://t.co/EL3VTUaz5R ""A Bioanalytical Toolkit to Support Oligonucleotide Therapeutics Throughout the Drug Development Pipeline"" Brooke Rock, PhD, Amgen . $AMGN seems to be researching a lot #RNAi for a company with only 2 $ARWR targets. More coming?",en,[],['https://www.oligotherapeutics.org/2019-annual-meeting/'],[],1,2,14,['rnai'],"['amgn', 'arwr']",https://twitter.com/MarkC53916729/status/1149308203076743169,False,,0,,,,,,,,[],,,,
1148644881855762432,1148644881855762432,2019-07-09 22:57:35 IST,2019-07-09,22:57:35,+0530,69421704,alexlash,Alex Lash,,No one has made a drug to fight cancers driven by the RAS gene family. (That's a lot of cancer.) Amgen $AMGN cracked that window open a tiny bit earlier this year. Let's see who else tries to climb through.,en,[],[],[],0,2,8,[],['amgn'],https://twitter.com/alexlash/status/1148644881855762432,False,https://twitter.com/BentheFidler/status/1148555377786703872,0,,,,,,,,[],,,,
1148555377786703872,1148555377786703872,2019-07-09 17:01:55 IST,2019-07-09,17:01:55,+0530,1330055544,benthefidler,Ben Fidler,,"After Amgen‚Äôs Spark, Revolution Med Nabs $100M to Push RAS Cancer Drugs  https://t.co/VyYqQoy455 by @sarahdc $AMGN",en,"[{'screen_name': 'sarahdc', 'name': 'sarah de crescenzo', 'id': '17799992'}]",['https://xconomy.com/san-francisco/2019/07/09/after-amgens-spark-revolution-med-nabs-100m-to-push-ras-cancer-drugs/'],[],0,0,7,[],['amgn'],https://twitter.com/BentheFidler/status/1148555377786703872,False,,0,,,,,,,,[],,,,
1147011595010289664,1147011595010289664,2019-07-05 10:47:29 IST,2019-07-05,10:47:29,+0530,401575573,dividendc2,dividendc2,,Mis TOP5 mejores compa√±√≠as - Healthcare -  Longevidad - largo plazo :  1: AbbVie Inc $ABBV  2: Amgen Inc $AMGN   3: Bristol-Myers Squibb Co $BMY  4: Medtronic PLC $MDT  5:  Biogen Inc $BIIB,ca,[],[],[],1,3,13,[],"['abbv', 'amgn', 'bmy', 'mdt', 'biib']",https://twitter.com/dividendc2/status/1147011595010289664,False,,0,,,,,,,,[],,,,
1143699854482452482,1143699854482452482,2019-06-26 07:27:48 IST,2019-06-26,07:27:48,+0530,921557521378238464,tekmunnee,TekMuNNee Picks,,#OptionsTrading #SwingTrades  #stocks Potential Targets (I am holding Contracts for each)  $AMGN üëÄs üîª $182.16 #amgen $COST üëÄs üîª $263.43 #Costco $EXPE üëÄs üîª $128.20 #expedia $ILMN üëÄs üîª $351.68 #illumina   Entries &amp; Exits Posted Live  @BlackBoxStocks,en,"[{'screen_name': 'blackboxstocks', 'name': 'blackboxstocks', 'id': '2317876500'}]",[],[],1,1,11,"['optionstrading', 'swingtrades', 'stocks', 'amgen', 'costco', 'expedia', 'illumina']","['amgn', 'cost', 'expe', 'ilmn']",https://twitter.com/tekmunnee/status/1143699854482452482,False,,0,,,,,,,,[],,,,
1138280087223058432,1138280087223058432,2019-06-11 08:31:35 IST,2019-06-11,08:31:35,+0530,922998314349445120,ivanhoff2,ivanhoff,,So much in life is being at the right place at the right time. The Amgen story via the book Loonshots. $amgn  https://t.co/3GOEWTh905,en,[],[],"['https://pbs.twimg.com/media/D8v7tI-U0AA_CXM.jpg', 'https://pbs.twimg.com/media/D8v7tI_UIAIC9gi.jpg']",6,41,150,[],['amgn'],https://twitter.com/ivanhoff2/status/1138280087223058432,False,,1,https://pbs.twimg.com/media/D8v7tI-U0AA_CXM.jpg,,,,,,,[],,,,
1138143532663943169,1138143532663943169,2019-06-10 23:28:58 IST,2019-06-10,23:28:58,+0530,3426014292,semodough,dough,,$AMGN Amgen has upsized its KRAS PhI trial to 158 patients from its original 60 $MRTX,en,[],[],[],0,1,15,[],"['amgn', 'mrtx']",https://twitter.com/semodough/status/1138143532663943169,False,,0,,,,,,,,[],,,,
1135533988028829698,1135533988028829698,2019-06-03 18:39:34 IST,2019-06-03,18:39:34,+0530,3426014292,semodough,dough,,$AMGN Amgen Announces First Clinical Data Evaluating Novel Investigational KRASG12C Inhibitor AMG 510 At ASCO 2019 $MRTX  https://t.co/ADFf9wpQJr,en,[],['http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-newsArticle&ID=2400393'],[],0,6,7,[],"['amgn', 'mrtx']",https://twitter.com/semodough/status/1135533988028829698,False,,0,,,,,,,,[],,,,
1135532137187352578,1135532137187352578,2019-06-03 18:32:13 IST,2019-06-03,18:32:13,+0530,102754598,johncendpts,John Carroll,,#ASCO19: Amgen grows more confident in KRAS G12C drug with a positive snapshot for lung cancer ‚Äî but it‚Äôs early days $AMGN  https://t.co/sEL23mcbTI,en,[],['https://endpts.com/asco19-amgen-grows-more-confident-in-kras-g12c-drug-with-a-positive-snapshot-for-lung-cancer-but-its-early-days/'],[],0,6,14,['asco19'],['amgn'],https://twitter.com/JohnCendpts/status/1135532137187352578,False,,0,,,,,,,,[],,,,
1130738888530649088,1130738888530649088,2019-05-21 13:05:33 IST,2019-05-21,13:05:33,+0530,401575573,dividendc2,dividendc2,,Mis TOP5 mejores compa√±√≠as - Healthcare -  Longevidad - largo plazo :  1: AbbVie Inc $ABBV  2: Amgen Inc $AMGN   3: Bristol-Myers Squibb Co $BMY  4: Medtronic PLC $MDT  5:  Biogen Inc $BIIB,ca,[],[],[],2,1,13,[],"['abbv', 'amgn', 'bmy', 'mdt', 'biib']",https://twitter.com/dividendc2/status/1130738888530649088,False,,0,,,,,,,,[],,,,
1125444576049713152,1122992432998535168,2019-05-06 22:27:51 IST,2019-05-06,22:27:51,+0530,223207812,truthtracer,truthtracer,,"After listening to multiple Amgen CC‚Äôs I‚Äôve concluded $AMGN is astutely conservative w/ prognostications unless they‚Äôre confident in the clinical (data) basis of their PR‚Äôs. This continues to validate the belief in additional, future collaborations. $ARWR $AMGN  https://t.co/r2PoTrak5x",en,[],[],['https://pbs.twimg.com/media/D55h2w_VUAMmM26.jpg'],0,0,10,[],"['amgn', 'arwr', 'amgn']",https://twitter.com/truthtracer/status/1125444576049713152,False,,1,https://pbs.twimg.com/media/D55h2w_VUAMmM26.jpg,,,,,,,[],,,,
1123543152273567744,1123543152273567744,2019-05-01 16:32:16 IST,2019-05-01,16:32:16,+0530,1029424313164881921,behindthebid,Behind The Bid,,"Wow.  204 companies reporting earnings today / last night.  Most notable are Apple $AAPL, Amgen $AMGN, CVS $CVS, Humana $HUM, Mondelez $MDLZ, Estee Lauder $EL, Advanced Micro Devices $AMD, Twilio $TWLO, Enphase Energy $ENPH, Tandem Diabetes $TNDM, Nu Skin $NUS",en,[],[],[],1,6,14,[],"['aapl', 'amgn', 'cvs', 'hum', 'mdlz', 'el', 'amd', 'twlo', 'enph', 'tndm', 'nus']",https://twitter.com/behindthebid/status/1123543152273567744,False,,0,,,,,,,,[],,,,
1123318811094990849,1123318811094990849,2019-05-01 01:40:49 IST,2019-05-01,01:40:49,+0530,913260122004086784,kessanman,Á±≥ÂõΩÊ†™ Ê±∫ÁÆó„Éû„É≥,,„Ç¢„É†„Ç∏„Çß„É≥Ê±∫ÁÆó Amgen (NASDAQ:AMGN) Q1'19 EPS(Non-GAAP) $3.56 ‰∫àÊÉ≥ +$0.08 Â£≤‰∏ä $5.56B (+0.2% Y/Y) ‰∫àÊÉ≥ +$10M  „Éê„Ç§„Ç™Ë£ΩËñ¨Â§ßÊâã„ÄÇÊ†™‰æ°„ÅØÊôÇÈñìÂ§ñ„Åß-1.2%  https://t.co/oAnUCguSfg  https://t.co/V8tocFQcqJ,ja,[],['http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-IRHome'],['https://pbs.twimg.com/media/D5bUgIOV4AA6_VS.png'],0,3,22,[],[],https://twitter.com/KessanMan/status/1123318811094990849,False,,1,https://pbs.twimg.com/media/D5bUgIOV4AA6_VS.png,,,,,,,[],,,,
1122904694576123917,1122904694576123917,2019-04-29 22:15:16 IST,2019-04-29,22:15:16,+0530,28436760,amgen,Amgen,,"In his 2018 letter to shareholders, #Amgen CEO Bob Bradway offers his perspective on what it will take to succeed in a dynamic global healthcare environment.  https://t.co/MobKgCiy3U $AMGN  https://t.co/IBMslejhbk",en,[],['http://bit.ly/2PEwoaP'],[],6,4,18,['amgen'],['amgn'],https://twitter.com/Amgen/status/1122904694576123917,False,,1,https://pbs.twimg.com/amplify_video_thumb/1122904550237564928/img/sWPJf_aYmxn2D3Rz.jpg,,,,,,,[],,,,
1116981972620988416,1116981972620988416,2019-04-13 14:00:29 IST,2019-04-13,14:00:29,+0530,401575573,dividendc2,dividendc2,,"Mis TOP 5 - Mejores compa√±√≠as BIOTECHNOLOGY , largo plazo:  1: Amgen Inc (AMGN)  2: Gilead Sciences Inc (GILD)  3: Celgene Corp (CELG)  4: Illumina Inc (ILMN)  5: Vertex Pharmaceuticals Inc (VRTX)",ca,[],[],[],2,0,14,[],[],https://twitter.com/dividendc2/status/1116981972620988416,False,,0,,,,,,,,[],,,,
1115688928936321024,1115688928936321024,2019-04-10 00:22:23 IST,2019-04-10,00:22:23,+0530,31546412,tradehawk,TradeHawk,,$AMGN Amgen gets FDA approval of Evenity for treatment of osteoporosis  https://t.co/aK9zhBG05U,en,[],['https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761062'],[],1,2,5,[],['amgn'],https://twitter.com/TradeHawk/status/1115688928936321024,False,,0,,,,,,,,[],,,,
1114113951766327297,1114113951766327297,2019-04-05 16:03:59 IST,2019-04-05,16:03:59,+0530,102754598,johncendpts,John Carroll,,"Any Big Pharma marriage counselors out there? Billions on the line, Novartis and Amgen exchange broadsides as Aimovig partnership erupts into a legal war $NVS $AMGN  https://t.co/WmSkOaLgfK",en,[],['https://endpts.com/billions-on-the-line-novartis-and-amgen-exchange-broadsides-as-aimovig-partnership-erupts-into-a-legal-war/'],[],2,1,6,[],"['nvs', 'amgn']",https://twitter.com/JohnCendpts/status/1114113951766327297,False,,0,,,,,,,,[],,,,
1113480803428773892,1113480803428773892,2019-04-03 22:08:05 IST,2019-04-03,22:08:05,+0530,15568127,themotleyfool,The Motley Fool,,"Every 10 weeks, David G. picks stocks, and this week is THAT week!  He's picking 5 stocks with a theme The Age of Miracles. One of the stocks is Amgen. For other stocks, you'll have to listen to today's episode of @RBIPodcast.  Fool On! $AMGN  https://t.co/dUjecIMj8t",en,"[{'screen_name': 'rbipodcast', 'name': 'rule breaker podcast', 'id': '3355060617'}]",[],[],4,3,20,[],['amgn'],https://twitter.com/themotleyfool/status/1113480803428773892,False,,1,https://pbs.twimg.com/ext_tw_video_thumb/1113480739188875264/pu/img/2wlWTYQlHfnsWEGe.jpg,,,,,,,[],,,,
1110492570365423616,1110492570365423616,2019-03-26 16:13:55 IST,2019-03-26,16:13:55,+0530,3426014292,semodough,dough,,"BMO #AACR19 $AMGN,expect  first preclinical data presentation for AMG 510 (KRAS G12C) to provide context for Amgen‚Äôs enthusiasm. For )CNST, updated CPI-1205 Phase 1 data could be a positive catalyst. For $TCRR, presentations from competitor therapies could further validate TC-210",en,[],[],[],1,3,8,['aacr19'],"['amgn', 'tcrr']",https://twitter.com/semodough/status/1110492570365423616,False,,0,,,,,,,,[],,,,
1104851923335893003,1104851923335893003,2019-03-11 02:40:00 IST,2019-03-11,02:40:00,+0530,20402945,cnbc,CNBC,,"These 3 stocks are trading at a great value, according to Smead Capital Management: - Discovery $DISCA - Walgreens $WBA - Amgen $AMGN  https://t.co/geFPTyddXC  https://t.co/uptaQVvTch",en,[],['https://cnb.cx/2EFHaIP'],[],0,3,19,[],"['disca', 'wba', 'amgn']",https://twitter.com/CNBC/status/1104851923335893003,False,,1,https://pbs.twimg.com/media/D0-5oX_XcAAKx53.jpg,,,,,,,[],,,,
1103645258791952388,1103645258791952388,2019-03-07 18:45:09 IST,2019-03-07,18:45:09,+0530,25998862,drugchannels,Adam J. Fein,,From @gracemarietweet: Good article on how #rebates distort the #drug market  - include a disturbing example of how patients are not benefiting from lower list price on #Repatha @Amgen $AMGN. Crazy.  https://t.co/ZMEokkOC2b @Forbes  https://t.co/l5DQrrASyc,en,"[{'screen_name': 'gracemarietweet', 'name': 'grace-marie turner', 'id': '59156687'}, {'screen_name': 'amgen', 'name': 'amgen', 'id': '28436760'}, {'screen_name': 'forbes', 'name': 'forbes', 'id': '91478624'}]",['https://drugch.nl/2EF46Jj'],['https://pbs.twimg.com/media/D1Dvg6JXQAAKuLA.png'],0,7,15,"['rebates', 'drug', 'repatha']",['amgn'],https://twitter.com/DrugChannels/status/1103645258791952388,False,,1,https://pbs.twimg.com/media/D1Dvg6JXQAAKuLA.png,,,,,,,[],,,,
1103603446479958016,1103603446479958016,2019-03-07 15:59:00 IST,2019-03-07,15:59:00,+0530,20402945,cnbc,CNBC,,"These 3 stocks are trading at a great value, according to Smead Capital Management: - Discovery $DISCA - Walgreens $WBA - Amgen $AMGN  https://t.co/geFPTyuOPa  https://t.co/kgMlM3dafN",en,[],['https://cnb.cx/2EFHaIP'],[],4,5,11,[],"['disca', 'wba', 'amgn']",https://twitter.com/CNBC/status/1103603446479958016,False,,1,https://pbs.twimg.com/media/D0-5oX_XcAAKx53.jpg,,,,,,,[],,,,
1100146701724274688,1100146701724274688,2019-02-26 03:03:08 IST,2019-02-26,03:03:08,+0530,1429550540,markmanadvisors,Markman Advisors LLC,,"Amgen wins on liability at Praluent trial; jury finds patents not invalid. Jury will be held for one or two days to try damages. Injunction against Praluent will not happen until after hearing, not yet scheduled, but not til May 2019 at earliest.  $AMGN $REGN #praluent #repatha",en,[],[],[],0,6,6,"['praluent', 'repatha']","['amgn', 'regn']",https://twitter.com/MarkmanAdvisors/status/1100146701724274688,False,,0,,,,,,,,[],,,,
1100134327822835712,1100134327822835712,2019-02-26 02:13:57 IST,2019-02-26,02:13:57,+0530,801116888,cfromhertz,Christian Fromhertz,,"*AMGEN PATENTS FOR CHOLESTEROL DRUG REPATHA ARE VALID, JURY SAYS $AMGN  *SANOFI, REGENERON LOSE VALIDITY TRIAL, CONCEDED INFRINGEMENT $SNY $REGN",en,[],[],[],1,3,7,[],"['amgn', 'sny', 'regn']",https://twitter.com/cfromhertz/status/1100134327822835712,False,,0,,,,,,,,[],,,,
1099767666389192704,1099767666389192704,2019-02-25 01:56:59 IST,2019-02-25,01:56:59,+0530,61342056,optionshawk,Joe Kunkle,,Amgen $AMGN one of the better looking and few short set-ups out thee on move under last week's low,en,[],[],[],0,2,9,[],['amgn'],https://twitter.com/OptionsHawk/status/1099767666389192704,False,,0,,,,,,,,[],,,,
1096096648403537921,1096096648403537921,2019-02-14 22:49:40 IST,2019-02-14,22:49:40,+0530,19717430,zbiotech,zach,,"*SANOFI, REGENERON WIN IPR CHALLENGE TO AMGEN ANTIBODY PATENT  $SNY $REGN $AMGN",ht,[],[],[],1,5,8,[],"['sny', 'regn', 'amgn']",https://twitter.com/zbiotech/status/1096096648403537921,False,,0,,,,,,,,[],,,,
1091521075631058944,1091517845157097472,2019-02-02 07:47:58 IST,2019-02-02,07:47:58,+0530,3279899995,michael007here,Michael,,"but wait, there's more. ARO-AAT Alpha-1 Liver Disease ARO-APOC3 Hypertriglyceridemia ARO-ANG3 Dyslipidemia ARO-ENaC Cystic Fibrosis ARO-HIF2 Renal Cell Carcinoma ARO-HBV Hepatitis B Partnered with Janssen AMG 890 Cardiovascular Disease Partnered w Amgen ARO-AMG1  $ARWR $JNJ $AMGN",en,[],[],[],0,1,16,[],"['arwr', 'jnj', 'amgn']",https://twitter.com/michael007here/status/1091521075631058944,False,,0,,,,,,,,[],,,,
1090378381730942977,1090378381730942977,2019-01-30 04:07:19 IST,2019-01-30,04:07:19,+0530,16732770,cnbcfastmoney,CNBC's Fast Money,,"Amgen lower in the after hours following its earnings release, top technician @verrone_chris gives instant reaction to the results $AMGN  https://t.co/zeBu8ePFgA",en,"[{'screen_name': 'verrone_chris', 'name': 'chris verrone', 'id': '778309437224136704'}]",[],[],1,2,8,[],['amgn'],https://twitter.com/CNBCFastMoney/status/1090378381730942977,False,,1,https://pbs.twimg.com/media/DyHNWwvWsAEQCMc.jpg,,,,,,,[],,,,
1090370276200714240,1090370276200714240,2019-01-30 03:35:06 IST,2019-01-30,03:35:06,+0530,28436760,amgen,Amgen,,#Amgen CEO reflects on delivery against 5 year commitments $AMGN  https://t.co/97sEk5Q40x  https://t.co/ACriXxmVDA,en,[],['http://bit.ly/2Wus29a'],['https://pbs.twimg.com/media/DyHF_MBWkAEE6zr.jpg'],2,0,18,['amgen'],['amgn'],https://twitter.com/Amgen/status/1090370276200714240,False,,1,https://pbs.twimg.com/media/DyHF_MBWkAEE6zr.jpg,,,,,,,[],,,,
1090364193319063555,1090364193319063555,2019-01-30 03:10:56 IST,2019-01-30,03:10:56,+0530,16732770,cnbcfastmoney,CNBC's Fast Money,,"Huge night for earnings as Apple, Advanced Micro, eBay and Amgen reports flood in. We will have wall-to-wall coverage coming up at 5pm! $AAPL $AMD $EBAY $AMGN  https://t.co/yfzzY82WtR",en,[],[],['https://pbs.twimg.com/media/DyHAcmwWkAAXY5f.jpg'],3,15,23,[],"['aapl', 'amd', 'ebay', 'amgn']",https://twitter.com/CNBCFastMoney/status/1090364193319063555,False,,1,https://pbs.twimg.com/media/DyHAcmwWkAAXY5f.jpg,,,,,,,[],,,,
1090357131868393472,1090357131868393472,2019-01-30 02:42:52 IST,2019-01-30,02:42:52,+0530,913260122004086784,kessanman,Á±≥ÂõΩÊ†™ Ê±∫ÁÆó„Éû„É≥,,„Ç¢„É†„Ç∏„Çß„É≥Ê±∫ÁÆó Amgen (NASDAQ:AMGN) Q4 EPS(Non-GAAP) $3.42 ‰∫àÊÉ≥ +$0.15 Â£≤‰∏ä $6.23B (+7.4% Y/Y) ‰∫àÊÉ≥ +$390M  „Éê„Ç§„Ç™„ÉÜ„ÇØ„Éé„É≠„Ç∏„ÉºÂ§ßÊâã„ÄÇÊ†™‰æ°„ÅØÊôÇÈñìÂ§ñ„Åß-2.5%  https://t.co/SJ5NUqTTYE  https://t.co/WsyqWpbYlU,ja,[],['http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-newsArticle&ID=2385241'],['https://pbs.twimg.com/media/DyG6B20V4AAd9gn.jpg'],0,2,9,[],[],https://twitter.com/KessanMan/status/1090357131868393472,False,,1,https://pbs.twimg.com/media/DyG6B20V4AAd9gn.jpg,,,,,,,[],,,,
1090354348033339392,1090354348033339392,2019-01-30 02:31:49 IST,2019-01-30,02:31:49,+0530,430841130,canuck2usa,CtheLightTrading,,"Amgen Q4 EPS $3.42 Beats $3.27 Estimate, Sales $6.23B Beat $5.86B Estimate $AMGN  https://t.co/Kul3gUQMP1 @benzinga",en,"[{'screen_name': 'benzinga', 'name': 'benzinga', 'id': '44060322'}]",['https://pro.benzinga.com'],[],0,8,6,[],['amgn'],https://twitter.com/canuck2usa/status/1090354348033339392,False,,0,,,,,,,,[],,,,
1088881552166187008,1088881552166187008,2019-01-26 00:59:27 IST,2019-01-26,00:59:27,+0530,19717430,zbiotech,zach,,"EXCLUSIVE-CVS SAYS PUTS NEW MIGRAINE DRUGS FROM TEVA AND ELI LILLY ON LIST OF COVERED MEDICINES, EXCLUDES AMGEN'S AIMOVIG  $TEVA $LLY $AMGN",en,[],[],[],2,3,7,[],"['teva', 'lly', 'amgn']",https://twitter.com/zbiotech/status/1088881552166187008,False,,0,,,,,,,,[],,,,
1088855043883683841,1088855043883683841,2019-01-25 23:14:07 IST,2019-01-25,23:14:07,+0530,223207812,truthtracer,truthtracer,,"DeCode Genetics (an Amgen subsidiary)  https://t.co/SAaDq1soTt ~Fast emerging, RNAi Gene silencing leader, $ARWR remains $AMGN ‚Äòs steadfastüß¨ silencing partner. A more comprehensive gene mutation understanding = additional disease targets üëâüèªSeems to imply a bright future for both.",en,[],['https://www.decode.com/decode-publishes-the-first-full-resolution-genetic-map-of-the-human-genome/'],[],2,0,15,[],"['arwr', 'amgn']",https://twitter.com/truthtracer/status/1088855043883683841,False,,0,,,,,,,,[],,,,
1087694512829419520,1087694512829419520,2019-01-22 18:22:34 IST,2019-01-22,18:22:34,+0530,3426014292,semodough,dough,,"MS $AMGN Amgen raised prices across many of its products, though the increases were modest at 3%.",en,[],[],[],0,1,5,[],['amgn'],https://twitter.com/semodough/status/1087694512829419520,False,,0,,,,,,,,[],,,,
1086763103944007680,1086632108548775936,2019-01-20 04:41:29 IST,2019-01-20,04:41:29,+0530,223207812,truthtracer,truthtracer,,@dsj1776 It seems entirely sequential to me that an expanded collaboration w/ $AMGN remains on the horizon. Amgen has remained very consistent with their relational praise (both directly &amp; indirectly) of $ARWR ~&amp; their TRiM platform. It doesn't logically end w/only a handful of targets.,en,[],[],[],2,0,9,[],"['amgn', 'arwr']",https://twitter.com/truthtracer/status/1086763103944007680,False,,0,,,,,,,,[],,,,
1084879260651843586,1084860377828126720,2019-01-14 23:55:46 IST,2019-01-14,23:55:46,+0530,42782695,berkeleyjr,Berkeley Lovelace,,The 12 companies that the panel requested information from:  AbbVie $ABBV Amgen $AMGN AstraZeneca $AZN Celgene $CELG Eli Lilly $LLY Johnson &amp; Johnson $JNJ Mallinckrodt $MNK Novartis $NVS Novo Nordisk $NVO Pfizer $PFE Sanofi $SNY Teva Pharmaceuticals $TEVA,en,[],[],[],1,3,6,[],"['abbv', 'amgn', 'azn', 'celg', 'lly', 'jnj', 'mnk', 'nvs', 'nvo', 'pfe', 'sny', 'teva']",https://twitter.com/BerkeleyJr/status/1084879260651843586,False,,0,,,,,,,,[],,,,
1082723627139661824,1082442532666204162,2019-01-09 01:10:03 IST,2019-01-09,01:10:03,+0530,1026340653209276417,markc53916729,Mark C,,"@Amgen @jimcramer @MadMoneyOnCNBC $AMGN is @jimcramer favorite biotech and $JNJ is his favorite Big Pharma, what do they have in common? Both have partner drugs in the clinic with $ARWR based on #RNAi , the innovative Nobel prize winning breakthrough that has great potential to revolutionize pharma. #HBV #LPa",en,"[{'screen_name': 'jimcramer', 'name': 'jim cramer', 'id': '14216123'}]",[],[],2,0,13,"['rnai', 'hbv', 'lpa']","['amgn', 'jnj', 'arwr']",https://twitter.com/MarkC53916729/status/1082723627139661824,False,,0,,,,,,,,"[{'screen_name': 'Amgen', 'name': 'Amgen', 'id': '28436760'}, {'screen_name': 'jimcramer', 'name': 'Jim Cramer', 'id': '14216123'}, {'screen_name': 'MadMoneyOnCNBC', 'name': 'Mad Money On CNBC', 'id': '16451932'}]",,,,
1080994737073651712,1080994737073651712,2019-01-04 06:40:03 IST,2019-01-04,06:40:03,+0530,25998862,drugchannels,Adam J. Fein,,Typically misleading article about #copay accumulators in @CNN - neglects fact that #PBMs target **single source** #specialty #drugs w/o #generic alternatives. Note details about @Amgen $AMGN direct reimbursement support for patients   https://t.co/roiOjJmNkf @KHNews #PBM,en,"[{'screen_name': 'cnn', 'name': 'cnn', 'id': '759251'}, {'screen_name': 'amgen', 'name': 'amgen', 'id': '28436760'}, {'screen_name': 'khnews', 'name': 'kaiser health news', 'id': '23999515'}]",['https://drugch.nl/2rZEmAz'],[],0,8,11,"['copay', 'pbms', 'specialty', 'drugs', 'generic', 'pbm']",['amgn'],https://twitter.com/DrugChannels/status/1080994737073651712,False,,0,,,,,,,,[],,,,
1078667712073777153,1078667712073777153,2018-12-28 20:33:17 IST,2018-12-28,20:33:17,+0530,18021517,jonathanrockoff,Jonathan Rockoff,,"Prescriptions of $AMGN's lower-priced cholesterol drug Repatha have gotten off to a good start, Evercore ISI's Raffat says. Amgen lowered the price after payer push-back stunted sales.  https://t.co/bHrsgoRert",en,[],[],['https://pbs.twimg.com/media/DvgyjEQWsAA8Yb8.jpg'],0,5,5,[],['amgn'],https://twitter.com/jonathanrockoff/status/1078667712073777153,False,,1,https://pbs.twimg.com/media/DvgyjEQWsAA8Yb8.jpg,,,,,,,[],,,,
1069926292466921472,1069926292466921472,2018-12-04 17:38:01 IST,2018-12-04,17:38:01,+0530,3460109487,endpts,Endpoints News,,#ASH18: Can Amgen break through the BCMA CAR-T line and take a BiTE of the multiple myeloma market? It won‚Äôt be quick or easy  https://t.co/DErTqCQORH $AMGN,en,[],['https://endpts.com/ash18-can-amgen-break-through-the-bcma-car-t-line-and-take-a-bite-of-the-multiple-myeloma-market-it-wont-be-quick-or-easy/'],[],0,1,5,['ash18'],['amgn'],https://twitter.com/endpts/status/1069926292466921472,False,,0,,,,,,,,[],,,,
1069777510320271361,1069777510320271361,2018-12-04 07:46:48 IST,2018-12-04,07:46:48,+0530,102754598,johncendpts,John Carroll,,#ASH18: Can Amgen break through the BCMA CAR-T line and take a BiTE of the multiple myeloma market? It won‚Äôt be quick or easy $AMGN  https://t.co/oxnntDpqtZ,en,[],['https://endpts.com/ash18-can-amgen-break-through-the-bcma-car-t-line-and-take-a-bite-of-the-multiple-myeloma-market-it-wont-be-quick-or-easy/'],[],1,1,8,['ash18'],['amgn'],https://twitter.com/JohnCendpts/status/1069777510320271361,False,,0,,,,,,,,[],,,,
1068150147304079362,1068150147304079362,2018-11-29 20:00:15 IST,2018-11-29,20:00:15,+0530,475309726,tradestation,TradeStation,,"Tech may have earned the headlines lately, but the #pharmaceutical sector seems to be luring the bulls. Take a look at charts from #bigpharma companies like #Pfizer $PFE, #Merck $MRK and #Amgen $AMGN.  https://t.co/My1iOz6AQC  https://t.co/fGkvbCDsqh",en,[],['https://bit.ly/2DPmsaG'],['https://pbs.twimg.com/media/DtLU5dhXgAs7Clt.jpg'],1,7,69,"['pharmaceutical', 'bigpharma', 'pfizer', 'merck', 'amgen']","['pfe', 'mrk', 'amgn']",https://twitter.com/TradeStation/status/1068150147304079362,False,,1,https://pbs.twimg.com/media/DtLU5dhXgAs7Clt.jpg,,,,,,,[],,,,
1057932739880468480,1057932739880468480,2018-11-01 15:19:55 IST,2018-11-01,15:19:55,+0530,913260122004086784,kessanman,Á±≥ÂõΩÊ†™ Ê±∫ÁÆó„Éû„É≥,,„Ç¢„É†„Ç∏„Çß„É≥Ê±∫ÁÆóÔºú10/30Ôºû Amgen (NASDAQ:AMGN) Q3 EPS $3.69 ‰∫àÊÉ≥ +$0.24 Â£≤‰∏ä $5.9B (+2.3% Y/Y) ‰∫àÊÉ≥ +$120M  „É¨„Éë„Éº„Çµ(È´ò„Ç≥„É¨„Çπ„ÉÜ„É≠„Éº„É´Ë°ÄÁóáÊ≤ªÁôÇÂâ§)„ÅÆÂ£≤‰∏äÈ´ò $120M(‰∫à: $163M) +35% Y/Y  „Éã„É•„Éº„É©„Çπ„Çø(ÁôΩË°ÄÁêÉÂ¢óÂº∑Ââ§)„ÅÆÂ£≤‰∏äÈ´ò $1.05B(‰∫à: $1.07B) -6% Y/Y   https://t.co/yA5ss3EfCY  https://t.co/QHOuSxzIZI,ja,[],['http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-newsArticle&ID=2374238'],['https://pbs.twimg.com/media/Dq6II65U0AEvRRN.jpg'],0,4,11,[],[],https://twitter.com/KessanMan/status/1057932739880468480,False,,1,https://pbs.twimg.com/media/Dq6II65U0AEvRRN.jpg,,,,,,,[],,,,
1056950913477144576,1056950913477144576,2018-10-29 22:18:29 IST,2018-10-29,22:18:29,+0530,223207812,truthtracer,truthtracer,,"BP is necessarily discretionary. $ARWR actively engaged in multiple negotiations, masked publicly for proprietary reasons. Both $AMGN &amp; $JNJ simply appeared after vague preliminary references. A third BP will likely surface, along w/a remarkably expanded Amgen collaboration, imo.",en,[],[],[],0,1,16,[],"['arwr', 'amgn', 'jnj']",https://twitter.com/truthtracer/status/1056950913477144576,False,,0,,,,,,,,[],,,,
1055191221948289025,1055191221948289025,2018-10-25 01:46:06 IST,2018-10-25,01:46:06,+0530,25998862,drugchannels,Adam J. Fein,,As I was saying: @Amgen $AMGN pops the gross-to-net bubble for #Repatha by launching new #NDC with list price that is 60% lower. Who's next?  https://t.co/yx42XXBS60  https://t.co/oFx8n0pUnb,en,"[{'screen_name': 'amgen', 'name': 'amgen', 'id': '28436760'}]",['https://drugch.nl/2Aq612m'],['https://pbs.twimg.com/media/DqTK0v_X4AUkSwA.jpg'],5,10,22,"['repatha', 'ndc']",['amgn'],https://twitter.com/DrugChannels/status/1055191221948289025,False,,1,https://pbs.twimg.com/media/DqTK0v_X4AUkSwA.jpg,,,,,,,[],,,,
1055189953947156481,1055189953947156481,2018-10-25 01:41:04 IST,2018-10-25,01:41:04,+0530,588507814,scripmandy,Mandy Jackson,,$AMGN Amgen Makes Repatha¬Æ (Evolocumab) Available In The US At A 60 Percent Reduced List Price:  https://t.co/iJdSO8YoZd,en,[],['https://www.amgen.com/media/news-releases/2018/10/amgen-makes-repatha-evolocumab-available-in-the-us-at-a-60-percent-reduced-list-price/'],[],5,1,5,[],['amgn'],https://twitter.com/ScripMandy/status/1055189953947156481,False,,0,,,,,,,,[],,,,
1055189084598099969,1055189084598099969,2018-10-25 01:37:36 IST,2018-10-25,01:37:36,+0530,47678782,megtirrell,Meg Tirrell,,"$AMGN cuts Repatha cholesterol drug price by almost 60%, following similar move from $REGN $SNY. But Amgen is actually lowering the list price instead of paying a bigger rebate. Its goal: lower copays for Medicare beneficiaries  https://t.co/5LamAPSXdC",en,[],['https://www.cnbc.com/2018/10/24/amgen-cuts-price-of-cholesterol-drug-by-almost-60percent.html'],[],4,24,49,[],"['amgn', 'regn', 'sny']",https://twitter.com/megtirrell/status/1055189084598099969,False,,0,,,,,,,,[],,,,
1053093878516105217,1053093878516105217,2018-10-19 06:52:00 IST,2018-10-19,06:52:00,+0530,3460109487,endpts,Endpoints News,,Amgen sharpens focus on genetic sequencing with $66M investment  https://t.co/2N2Oo1J9jv $AMGN,en,[],['https://endpts.com/amgen-sharpens-focus-on-genetic-sequencing-with-66m-investment/'],[],1,6,13,[],['amgn'],https://twitter.com/endpts/status/1053093878516105217,False,,0,,,,,,,,[],,,,
1049568155968909312,1049395006438629376,2018-10-09 13:22:03 IST,2018-10-09,13:22:03,+0530,67066114,dhovekamp42,"`((,(Dieter 'Hovekamp)))",,@Brownynut @BrianUherek @davidal156 If you look at the competitor $AMGN Amgen Blincyto it is unlikely that an effective dose 4 $AFMD AFM11 would be free of SAE's -- but like CAR-T cell therapies it maybe well controllable if detected early -- 4 comparison see   https://t.co/qPWGmXgiIL 2  https://t.co/qdKDQGCjEs,en,[],['https://www.blincyto.com/hcp/rr/efficacy/'],['https://pbs.twimg.com/media/DpDQQX3WsAEUAhc.jpg'],1,2,9,[],"['amgn', 'afmd']",https://twitter.com/dhovekamp42/status/1049568155968909312,False,,1,https://pbs.twimg.com/media/DpDQQX3WsAEUAhc.jpg,,,,,,,"[{'screen_name': 'Brownynut', 'name': 'craig', 'id': '67475546'}, {'screen_name': 'BrianUherek', 'name': 'Brian Uherek', 'id': '3261783863'}, {'screen_name': 'davidal156', 'name': 'David Vysosky', 'id': '742399482235478017'}]",,,,
1047841315248115712,1047841315248115712,2018-10-04 19:00:12 IST,2018-10-04,19:00:12,+0530,475309726,tradestation,TradeStation,,"The health care sector has seen unprecedented success in Q3. Find out why Amgen ($AMGN), Medtronic ($MDT), and Abbot Laboratories ($ABT) are finding themselves at an all-time high. #TradeThatTrend  https://t.co/dZfZW749xX",en,[],[],[],0,0,8,['tradethattrend'],[],https://twitter.com/TradeStation/status/1047841315248115712,False,,1,https://pbs.twimg.com/ext_tw_video_thumb/1047841273028071424/pu/img/eCQCjlI6YPNfFqXT.jpg,,,,,,,[],,,,
1044585185822466049,1044585185822466049,2018-09-25 19:21:30 IST,2018-09-25,19:21:30,+0530,57124794,annaedney,Anna Edney,,"Pfizer wants to meet rivals J&amp;J, Amgen and Roche at the flagpole after school  https://t.co/kkYfJ6ZHou via @JaredSHopkins $PFE $AMGN $JNJ $ROG",en,"[{'screen_name': 'jaredshopkins', 'name': 'jared s. hopkins', 'id': '42814585'}]",['https://www.bloomberg.com/news/articles/2018-09-25/brand-name-drugmakers-turn-on-each-other-in-fight-for-new-market'],[],2,8,12,[],"['pfe', 'amgn', 'jnj', 'rog']",https://twitter.com/annaedney/status/1044585185822466049,False,,0,,,,,,,,[],,,,
1044326201089814533,1044326201089814533,2018-09-25 02:12:23 IST,2018-09-25,02:12:23,+0530,14886375,stocktwits,Stocktwits,,"22 stocks hit all-time highs today.  Amgen $AMGN, Salesforce $CRM, Aflac $AFL, and Ross Stores $ROST all made the list. Here's who else made history:   https://t.co/np7vYBIJmz",en,[],['https://stocktwits.com/361Capital/message/138580956'],[],1,10,20,[],"['amgn', 'crm', 'afl', 'rost']",https://twitter.com/Stocktwits/status/1044326201089814533,False,,0,,,,,,,,[],,,,
1040623150474584064,1040623150474584064,2018-09-14 20:57:47 IST,2018-09-14,20:57:47,+0530,223207812,truthtracer,truthtracer,,"Amgen Inc. $AMGN at the BofAML Global Health Conference 2018 Presentation ~Presenting AMG-890 as a ""Key pipeline opportunity"" today. Allowing the world to see one of $ARWR 's KEY contributions  https://t.co/Rzoa8uou7g",en,[],[],"['https://pbs.twimg.com/media/DnEId30UYAEcz1j.jpg', 'https://pbs.twimg.com/media/DnEJLA4U4AI-T57.jpg']",1,3,28,[],"['amgn', 'arwr']",https://twitter.com/truthtracer/status/1040623150474584064,False,,1,https://pbs.twimg.com/media/DnEId30UYAEcz1j.jpg,,,,,,,[],,,,
1040409461683179520,1040405448573243393,2018-09-14 06:48:40 IST,2018-09-14,06:48:40,+0530,1026340653209276417,markc53916729,Mark C,,"@saadvisory Actually $ARWR investor/analyst day is Oct 16th, AASLD begins Nov 9. Also $AMGN is deciding on whether to move ARO-AMG1 into clinic, not if funding continues. Amgen has already picked up AMG-890, did so in early August.",en,[],[],[],0,0,14,[],"['arwr', 'amgn']",https://twitter.com/MarkC53916729/status/1040409461683179520,False,,0,,,,,,,,"[{'screen_name': 'saadvisory', 'name': 'william velmer', 'id': '49530226'}]",,,,
1040268877127671808,1040268877127671808,2018-09-13 21:30:02 IST,2018-09-13,21:30:02,+0530,28436760,amgen,Amgen,,"As the healthcare ecosystem transforms, #Amgen is ready. ‚ÄúInnovation is becoming more important, not less,‚Äù said Amgen CEO Bob Bradway at the Morgan Stanley Global Healthcare Conference. $AMGN  https://t.co/htD89b9hZI",en,[],[],[],0,6,17,['amgen'],['amgn'],https://twitter.com/Amgen/status/1040268877127671808,False,,1,https://pbs.twimg.com/amplify_video_thumb/1040023834022174720/img/Ga9zOWXF4UeVt-6d.jpg,,,,,,,[],,,,
1039238970989838341,1039238970989838341,2018-09-11 01:17:33 IST,2018-09-11,01:17:33,+0530,102754598,johncendpts,John Carroll,,"This is mostly another ding for $GSK -- Analyst offers Amgen a boost for its rival anti-BCMA BiTE, blemishing GSK as well as CAR-T rivals Celgene and bluebird $AMGN $CELG $BLUE  https://t.co/os0sokZFA9",en,[],['https://endpts.com/?p=168199&preview=true'],[],3,6,14,[],"['gsk', 'amgn', 'celg', 'blue']",https://twitter.com/JohnCendpts/status/1039238970989838341,False,,0,,,,,,,,[],,,,
1039181246142861312,1039181246142861312,2018-09-10 21:28:10 IST,2018-09-10,21:28:10,+0530,3426014292,semodough,dough,,"Baird $AMGN Amgen has been beating a drum around BiTE as a modality that is capable of competing with the efficacy of CART but in a much more user-friendly way. If these results hold up and can be extrapolated to other targets, the BiTE approach could be a real risk to CART $GILD",en,[],[],[],0,1,15,[],"['amgn', 'gild']",https://twitter.com/semodough/status/1039181246142861312,False,,0,,,,,,,,[],,,,
1038037045904588800,1038037045904588800,2018-09-07 17:41:32 IST,2018-09-07,17:41:32,+0530,102754598,johncendpts,John Carroll,,"AstraZeneca, Amgen roll up a ‚Äòbreakthrough‚Äô at the FDA in hot pursuit of a potential game changer in asthma $AZN $AMGN   https://t.co/WIqNjGDWXI",en,[],['https://endpts.com/astrazeneca-amgen-roll-up-a-breakthrough-at-the-fda-in-hot-pursuit-of-a-potential-game-changer-in-asthma/'],[],2,6,12,[],"['azn', 'amgn']",https://twitter.com/JohnCendpts/status/1038037045904588800,False,,0,,,,,,,,[],,,,
1036105232261017600,1036105232261017600,2018-09-02 09:45:11 IST,2018-09-02,09:45:11,+0530,906328017986899968,the_chart_life,"Ian McMillan, CMT",,"$AMGN Amgen ...Pushing up against resistance again. Would be long if we can get above ~$203. Biotech very strong lately, too.  https://t.co/8vlMimkRA1",en,[],[],['https://pbs.twimg.com/media/DmD8N6EX0AAEUto.jpg'],0,1,10,[],['amgn'],https://twitter.com/the_chart_life/status/1036105232261017600,False,,1,https://pbs.twimg.com/media/DmD8N6EX0AAEUto.jpg,,,,,,,[],,,,
1035128298462949376,1035128298462949376,2018-08-30 17:03:12 IST,2018-08-30,17:03:12,+0530,102754598,johncendpts,John Carroll,,Amgen vet Laura Hamill takes commercial reins at Gilead amid executive shakeup $AMGN $GILD @AmberTongPW   https://t.co/lfF1XB1BWi,en,"[{'screen_name': 'ambertongpw', 'name': 'amber tong', 'id': '746441781588426752'}]",['https://endpts.com/amgen-vet-laura-hamill-takes-commercial-reins-at-gilead-amid-executive-shakeup/'],[],0,4,5,[],"['amgn', 'gild']",https://twitter.com/JohnCendpts/status/1035128298462949376,False,,0,,,,,,,,[],,,,
1023183386293227521,1023183386293227521,2018-07-28 17:58:23 IST,2018-07-28,17:58:23,+0530,3017621038,bioboyscout,BioBoyScout,,"BP is starting to realize like Amgen did - that genetic data can not only speed up drug development, but greatly increase the odds of success. RNAi is the perfect complementing technology and will play a major role. $ARWR $GSK $AMGN #RNAi",en,[],[],[],0,2,16,['rnai'],"['arwr', 'gsk', 'amgn']",https://twitter.com/BioBoyScout/status/1023183386293227521,False,https://twitter.com/DrLizSamander/status/1023175653275971590,0,,,,,,,,[],,,,
1022790278493757440,1022601336188227585,2018-07-27 15:56:19 IST,2018-07-27,15:56:19,+0530,862870446,bikerieder,BikeRiederüá®üá≠,,@RNAiAnalyst $AMGN is not only S. Harper. The RNAi approach with $ARWR must have been approved by the board. So if he leaves Amgen by the end of the year only - no rushing out! - the partnership extension will be done with him,en,[],[],[],1,0,11,[],"['amgn', 'arwr']",https://twitter.com/BikeRieder/status/1022790278493757440,False,,0,,,,,,,,"[{'screen_name': 'RNAiAnalyst', 'name': 'Multivalent Dirk Haussecker', 'id': '409194010'}]",,,,
1022592706969788416,1022592706969788416,2018-07-27 02:51:14 IST,2018-07-27,02:51:14,+0530,18021517,jonathanrockoff,Jonathan Rockoff,,"$AMGN commercial head Tony Hooper and R&amp;D chief Sean Harper to leave the company. Murdo Gordon, who had been at $BMY, becomes commercial chief. David Reese, who has been leading translational science and oncology at Amgen, to helm all of R&amp;D.  https://t.co/ZnmWIjRyu4",en,[],['https://bit.ly/2LEI1iG'],[],1,13,8,[],"['amgn', 'bmy']",https://twitter.com/jonathanrockoff/status/1022592706969788416,False,,0,,,,,,,,[],,,,
1022589439246123008,1022589439246123008,2018-07-27 02:38:15 IST,2018-07-27,02:38:15,+0530,913260122004086784,kessanman,Á±≥ÂõΩÊ†™ Ê±∫ÁÆó„Éû„É≥,,„Ç¢„É†„Ç∏„Çß„É≥Ê±∫ÁÆó Amgen (NASDAQ:AMGN) Q2 EPS $3.83 ‰∫àÊÉ≥ +$0.29 Â£≤‰∏ä $6.06B (+4.3% Y/Y) ‰∫àÊÉ≥ +$330M  „Éê„Ç§„Ç™„ÉÜ„ÇØ„Éé„É≠„Ç∏„Éº‰ºÅÊ•≠„ÄÇÊ†™‰æ°„ÅØÊôÇÈñìÂ§ñ„Åß+1.5%  https://t.co/1XSkldCPUk  https://t.co/QGsVTvjsH0,ja,[],['http://investors.amgen.com/'],['https://pbs.twimg.com/media/DjD3O7aUYAAYTMS.jpg'],0,2,9,[],[],https://twitter.com/KessanMan/status/1022589439246123008,False,,1,https://pbs.twimg.com/media/DjD3O7aUYAAYTMS.jpg,,,,,,,[],,,,
1022589201307643905,1022589201307643905,2018-07-27 02:37:19 IST,2018-07-27,02:37:19,+0530,274233761,bradloncar,Brad Loncar,,"$AMGN says the answer to ""30 Down"" in today's NY Times Crossword Puzzle is Amgen.  Anybody have the question?",en,[],[],[],2,1,8,[],['amgn'],https://twitter.com/bradloncar/status/1022589201307643905,False,,0,,,,,,,,[],,,,
1022578831096537089,1022578831096537089,2018-07-27 01:56:06 IST,2018-07-27,01:56:06,+0530,102754598,johncendpts,John Carroll,,Amgen R&amp;D chief Sean Harper hits the exits with a one-way ticket to early-stage biotech $AMGN  https://t.co/lWrptJwRzJ,en,[],['https://endpts.com/amgen-rd-chief-sean-harper-hits-the-exits-with-a-one-way-ticket-to-early-stage-biotech/'],[],1,4,13,[],['amgn'],https://twitter.com/JohnCendpts/status/1022578831096537089,False,,0,,,,,,,,[],,,,
1021454950050672640,1021454950050672640,2018-07-23 23:30:12 IST,2018-07-23,23:30:12,+0530,223207812,truthtracer,truthtracer,,"Fair analysis but very conservative~no inclusion of the $AMGN effect. Amgen previously, publicly endorsed Arrowhead‚Äôs cardiovascular Lp(a) contribution to their pharmaceutical arsenal &amp; it remains a virtual certainty that additional collaborations are near. $ARWR  https://t.co/DjemDbV39Q",en,[],[],['https://pbs.twimg.com/media/Dizv3S2VQAASpzI.jpg'],1,0,12,[],"['amgn', 'arwr']",https://twitter.com/truthtracer/status/1021454950050672640,False,,1,https://pbs.twimg.com/media/Dizv3S2VQAASpzI.jpg,,,,,,,[],,,,
1020071194480005120,1020055054043287555,2018-07-20 03:51:39 IST,2018-07-20,03:51:39,+0530,3017621038,bioboyscout,BioBoyScout,,"@TRiMBio1 @RNAiAnalyst I think $ARWR's ARO-ENaC has $AMGN written all over it. Wondering how it started? Check out Amgen's research from 2016,  https://t.co/B1y5sO8810 #RNAi",en,[],['https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2016.193.1_MeetingAbstracts.A5564'],[],1,0,15,['rnai'],"['arwr', 'amgn']",https://twitter.com/BioBoyScout/status/1020071194480005120,False,,0,,,,,,,,"[{'screen_name': 'TRiMBio1', 'name': 'TRiMBio', 'id': '998954982463320065'}, {'screen_name': 'RNAiAnalyst', 'name': 'Multivalent Dirk Haussecker', 'id': '409194010'}]",,,,
1007669274436145152,1007668296987168774,2018-06-15 22:30:51 IST,2018-06-15,22:30:51,+0530,3017621038,bioboyscout,BioBoyScout,,"Key quotes from $AMGN: ""No company has made a larger bet on using human genetics to drive R&amp;D than Amgen."" ""... newer technologies like RNA interference can address some hard-to-hit proteins by intercepting the RNA used to make the proteins."" $ARWR #RNAi",en,[],[],[],1,0,19,['rnai'],"['amgn', 'arwr']",https://twitter.com/BioBoyScout/status/1007669274436145152,False,,0,,,,,,,,[],,,,
1007390090413334528,1007390090413334528,2018-06-15 04:01:28 IST,2018-06-15,04:01:28,+0530,223207812,truthtracer,truthtracer,,No great mystery $AMGN chose Lp(a) (aka~AMG-890) as a CV target~1 in 5 people worldwide have inherited Lp(a)~or 63M Americans. This $ARWR brainchild was emphasized by $AMGN during the Goldman Sachs HCC. Amgen implie  great confidence in its bid 4 clinical success. üîúValidation.  https://t.co/UdSqSNXzCS,en,[],[],"['https://pbs.twimg.com/media/DfryMNHVMAA9Lz0.jpg', 'https://pbs.twimg.com/media/DfryOXqUEAAjylw.jpg']",2,2,24,[],"['amgn', 'arwr', 'amgn']",https://twitter.com/truthtracer/status/1007390090413334528,False,,1,https://pbs.twimg.com/media/DfryMNHVMAA9Lz0.jpg,,,,,,,[],,,,
1006345289693876224,1004753343254859776,2018-06-12 06:49:48 IST,2018-06-12,06:49:48,+0530,3279899995,michael007here,Michael,,"@BioBoyScout To take it one step further, it is my belief that Sean Harper does indeed understand exactly what $ARWR and RNAi can do for $AMGN and the world. Watch the video again that @BioBoyScout posted. Amgen wants to be THE cutting edge of Biotechnology, I think we can helpüòä!",en,"[{'screen_name': 'bioboyscout', 'name': 'bioboyscout', 'id': '3017621038'}]",[],[],0,0,14,[],"['arwr', 'amgn']",https://twitter.com/michael007here/status/1006345289693876224,False,,0,,,,,,,,"[{'screen_name': 'BioBoyScout', 'name': 'BioBoyScout', 'id': '3017621038'}]",,,,
1006182251107762182,1006182251107762182,2018-06-11 20:01:57 IST,2018-06-11,20:01:57,+0530,223207812,truthtracer,truthtracer,,Seems the perception is that $AMGN is poised to make a substantial collaborative move. The multiple positions being filled virtually concurrently by both $ARWR &amp; Amgen certainly do nothing to dispel that notion. The science may be tricky but institutions can read signs.,en,[],[],[],1,2,18,[],"['amgn', 'arwr']",https://twitter.com/truthtracer/status/1006182251107762182,False,,0,,,,,,,,[],,,,
1004341350098186240,1004341350098186240,2018-06-06 18:06:52 IST,2018-06-06,18:06:52,+0530,3017621038,bioboyscout,BioBoyScout,,I wonder where $ARWR got the idea of an inhaled RNAi sodium channel blocker? Could it be from $AMGN? Interesting Amgen abstract from 2016. Kudos to Arrowhead for developing RNAi aerosol inhalation delivery. I see an ARO-ENaC partnership coming soon.  https://t.co/KRo9DpZ2fh,en,[],['https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2016.193.1_MeetingAbstracts.A5564'],[],1,2,19,[],"['arwr', 'amgn']",https://twitter.com/BioBoyScout/status/1004341350098186240,False,,0,,,,,,,,[],,,,
1003934305012408320,1003934305012408320,2018-06-05 15:09:25 IST,2018-06-05,15:09:25,+0530,3426014292,semodough,dough,,"Baird $AMGN investors begin to face reality of loss of exclusivity of one of Amgen's two biggest franchises. This approval will likely increase the urgency to see new launches, such as Aimovig and Repatha, transition into blockbusters. Also my comment urgency for M&amp;A goes up also",en,[],[],[],2,2,7,[],['amgn'],https://twitter.com/semodough/status/1003934305012408320,False,,0,,,,,,,,[],,,,
1002901416334254080,1002901416334254080,2018-06-02 18:45:05 IST,2018-06-02,18:45:05,+0530,25998862,drugchannels,Adam J. Fein,,"Is a new #drug pricing paradigm emerging? (1) @Amgen $AMGN launches Aimovig at a non-specialty list price  https://t.co/k7HWnoUlwv   (2) @LillyPad $LLY launches OLUMIANT with a list price that is ""60% less than the leading TNF inhibitor""  https://t.co/ckRcOOJ0wG",en,"[{'screen_name': 'amgen', 'name': 'amgen', 'id': '28436760'}, {'screen_name': 'lillypad', 'name': 'eli lilly and company', 'id': '172496840'}]","['https://drugch.nl/2swyVc4', 'https://drugch.nl/2sAs6q1']",[],2,13,22,['drug'],"['amgn', 'lly']",https://twitter.com/DrugChannels/status/1002901416334254080,False,,0,,,,,,,,[],,,,
997254794535305218,997254794535305218,2018-05-18 04:47:25 IST,2018-05-18,04:47:25,+0530,102094857,adamfeuerstein,Adam Feuerstein,,Amgen‚Äôs new migraine drug will cost 30 percent less than Wall Street expected  https://t.co/0OwtWKNHr5 via @damiangarde $AMGN,en,"[{'screen_name': 'damiangarde', 'name': 'damian garde', 'id': '529704495'}]",['https://www.statnews.com/2018/05/17/amgen-migraine-drug-cost-wall-st/'],[],3,9,32,[],['amgn'],https://twitter.com/adamfeuerstein/status/997254794535305218,False,,0,,,,,,,,[],,,,
997251590724767744,997251590724767744,2018-05-18 04:34:41 IST,2018-05-18,04:34:41,+0530,102754598,johncendpts,John Carroll,,"Amgen, Novartis ready to roll as FDA green lights blockbuster campaign for migraine drug ‚Äî priced at $6,900 $AMGN $NVS  https://t.co/IwFLB7Tv2s",en,[],['https://endpts.com/amgen-novartis-ready-to-roll-as-fda-green-lights-blockbuster-campaign-for-migraine-drug-priced-at-6900/'],[],0,8,6,[],"['amgn', 'nvs']",https://twitter.com/JohnCendpts/status/997251590724767744,False,,0,,,,,,,,[],,,,
991271119771570178,991271119771570178,2018-05-01 16:30:26 IST,2018-05-01,16:30:26,+0530,1330055544,benthefidler,Ben Fidler,,"Express Scripts Picks Regeneron Over Amgen, Cuts Heart Drug Price  https://t.co/1NCi3wW6dj $REGN $AMGN $ESRX #PCSK9",en,[],['https://www.xconomy.com/new-york/2018/05/01/express-scripts-picks-regeneron-over-amgen-cuts-heart-drug-price/'],[],0,5,4,['pcsk9'],"['regn', 'amgn', 'esrx']",https://twitter.com/BentheFidler/status/991271119771570178,False,,0,,,,,,,,[],,,,
986888436878626816,986888436878626816,2018-04-19 14:15:13 IST,2018-04-19,14:15:13,+0530,102754598,johncendpts,John Carroll,,Novartis poaches Bristol-Myers/Amgen vet John Tsai for top drug development post in a $9B organization $NVS $AMGN  https://t.co/SSAzKrXNgR,en,[],['https://endpts.com/novartis-poaches-bristol-myers-amgen-vet-john-tsai-for-top-drug-development-post-in-a-9b-organization/'],[],0,4,8,[],"['nvs', 'amgn']",https://twitter.com/JohnCendpts/status/986888436878626816,False,,0,,,,,,,,[],,,,
964437462893453312,964437462893453312,2018-02-16 15:23:04 IST,2018-02-16,15:23:04,+0530,2494896473,biotech2050,Biotech2050 üíé‚úã,,#genome #editing to #cure #HIV #infection (Using $SGMO Zinc finger)  @GileadSciences @abbvie @pfizer @bmsnews @Celgene @NovartisScience @VasNarasimhan @Amgen @biogen @sanofi @Roche  $GILD $ABBV $PFE $BMY $CELG $NVS $AMGN $BIIB $SNY $RHHBY   https://t.co/irVjPxJyJJ,en,"[{'screen_name': 'gileadsciences', 'name': 'gilead sciences', 'id': '309728693'}, {'screen_name': 'abbvie', 'name': 'abbvie', 'id': '531892451'}, {'screen_name': 'pfizer', 'name': 'pfizer inc.', 'id': '56488059'}, {'screen_name': 'bmsnews', 'name': 'bristol myers squibb', 'id': '34010976'}, {'screen_name': 'celgene', 'name': 'jin', 'id': '1350978062125588490'}, {'screen_name': 'novartisscience', 'name': 'novartis science', 'id': '2260514101'}, {'screen_name': 'vasnarasimhan', 'name': 'vas narasimhan', 'id': '723488741348782080'}, {'screen_name': 'amgen', 'name': 'amgen', 'id': '28436760'}, {'screen_name': 'biogen', 'name': 'biogen', 'id': '155650832'}, {'screen_name': 'sanofi', 'name': 'sanofi', 'id': '35846368'}, {'screen_name': 'roche', 'name': 'roche', 'id': '20815041'}]",['https://www.youtube.com/watch?v=WPp-ip0Nwyk'],[],1,4,7,"['genome', 'editing', 'cure', 'hiv', 'infection']","['sgmo', 'gild', 'abbv', 'pfe', 'bmy', 'celg', 'nvs', 'amgn', 'biib', 'sny', 'rhhby']",https://twitter.com/Biotech2050/status/964437462893453312,False,,0,,,,,,,,[],,,,
963798492052418561,963798492052418561,2018-02-14 21:04:01 IST,2018-02-14,21:04:01,+0530,25998862,drugchannels,Adam J. Fein,,"Intriguing: @Amgen $AMGN calls out ""co-pay accumulator adjustment or maximization programs"" as a risk factor in its 2017 10-K filing - see page 25  https://t.co/upKjxbsnwb   P.S. My $0.02 here:  https://t.co/UY1Tu0zq6Y  https://t.co/IWltdt6IRg",en,"[{'screen_name': 'amgen', 'name': 'amgen', 'id': '28436760'}]","['http://drugch.nl/2Hejfkk', 'http://drugch.nl/2EQM8SH']",['https://pbs.twimg.com/media/DWAZnyfV4AAOlW3.jpg'],2,12,10,[],['amgn'],https://twitter.com/DrugChannels/status/963798492052418561,False,,1,https://pbs.twimg.com/media/DWAZnyfV4AAOlW3.jpg,,,,,,,[],,,,
962772263991939072,962772263991939072,2018-02-12 01:06:09 IST,2018-02-12,01:06:09,+0530,427877977,portefeuillefun,Volker Schulz,,#Amgen ‚Äòlooking hard‚Äô at striking deals using $27bn cash pile  https://t.co/eMw1gJhXHa. $AMGN $IBB $XBI,en,[],['https://www.ft.com/content/02106674-0867-11e8-9650-9c0ad2d7c5b5'],[],1,1,7,['amgen'],"['amgn', 'ibb', 'xbi']",https://twitter.com/portefeuillefun/status/962772263991939072,False,,0,,,,,,,,[],,,,
962764367950364672,962764367950364672,2018-02-12 00:34:47 IST,2018-02-12,00:34:47,+0530,471309350,groman100,$PENNY KING,,Amgen ‚Äòlooking hard‚Äô at striking deals using $27bn cash pile  https://t.co/UYXLEu0RuG $amgn buy $mbio or $tgtx or $sens,en,[],['https://www.ft.com/content/02106674-0867-11e8-9650-9c0ad2d7c5b5?segmentid=acee4131-99c2-09d3-a635-873e61754ec6'],[],0,2,5,[],"['amgn', 'mbio', 'tgtx', 'sens']",https://twitter.com/groman100/status/962764367950364672,False,,0,,,,,,,,[],,,,
962709301415555073,962709301415555073,2018-02-11 20:55:58 IST,2018-02-11,20:55:58,+0530,884391852119642112,trading_mz,Mz Trading,,"*AMGEN SEEKS DEALS, FINDING TARGETS IS HARD, CEO SAYS: FT  $AMGN",en,[],[],[],4,3,12,[],['amgn'],https://twitter.com/trading_mz/status/962709301415555073,False,,0,,,,,,,,[],,,,
959407879425089536,959407879425089536,2018-02-02 18:17:18 IST,2018-02-02,18:17:18,+0530,102754598,johncendpts,John Carroll,,Amgen‚Äôs $70B in ‚Äòdeal capacity‚Äô post-tax reform puts the spotlight on ‚Äòbig things‚Äô in M&amp;A ‚Äî analyst $AMGN  https://t.co/GmzwVZTYeF,en,[],['https://endpts.com/amgens-70b-in-deal-capacity-post-tax-reform-puts-the-spotlight-on-big-things-in-ma-analyst/'],[],5,15,18,[],['amgn'],https://twitter.com/JohnCendpts/status/959407879425089536,False,,0,,,,,,,,[],,,,
952324080211976193,952324080211976193,2018-01-14 05:08:48 IST,2018-01-14,05:08:48,+0530,223207812,truthtracer,truthtracer,,$ARWR reached $27.00+ in 2014 with institutional inflow that didn‚Äôt then have the lucidity $AMGN has recently advanced w/the TRiM-subcutaneous platform. It appears institutional money has discerned risk is mitigated with Amgen‚Äôs roll out of the adopted AMG-890 ($ARWR lineage).,en,[],[],[],2,1,16,[],"['arwr', 'amgn']",https://twitter.com/truthtracer/status/952324080211976193,False,,0,,,,,,,,[],,,,
948591306946703360,948591306946703360,2018-01-03 21:56:06 IST,2018-01-03,21:56:06,+0530,223207812,truthtracer,truthtracer,,Notice too that $AMGN is publicizing AMG-890. $ARWR contribution to Amgen‚Äôs cardiovascular toolkit. That tends to perk up the street...  https://t.co/NAabviWC52,en,[],[],['https://pbs.twimg.com/media/DSoSxBUU0AAvwH7.jpg'],2,2,11,[],"['amgn', 'arwr']",https://twitter.com/truthtracer/status/948591306946703360,False,,1,https://pbs.twimg.com/media/DSoSxBUU0AAvwH7.jpg,,,,,,,[],,,,
942100969978056704,942100969978056704,2017-12-17 00:05:49 IST,2017-12-17,00:05:49,+0530,187539751,dailytradealert,Daily Trade Alert,,Amgen $AMGN yields 2.6% and looks undervalued. See @JasonFieber walk through his analysis of our most recent Undervalued Dividend Growth Stock of the Week.  https://t.co/8CEQ31Hp9m  https://t.co/4zetCpl9z3,en,"[{'screen_name': 'jasonfieber', 'name': 'jason fieber', 'id': '3510011420'}]",['https://goo.gl/NhMh35'],['https://pbs.twimg.com/media/DRMDz1WVoAAQUcY.jpg'],0,2,6,[],['amgn'],https://twitter.com/DailyTradeAlert/status/942100969978056704,False,,1,https://pbs.twimg.com/media/DRMDz1WVoAAQUcY.jpg,,,,,,,[],,,,
926523854943674368,926523854943674368,2017-11-04 00:27:55 IST,2017-11-04,00:27:55,+0530,102754598,johncendpts,John Carroll,,#3 Novartis and Amgen launch new Alzheimer‚Äôs study $NVS $AMGN  https://t.co/gspy1lfUeo,en,[],['https://endpts.com/novartis-and-amgen-launch-new-alzheimers-study/'],[],0,3,6,[],"['nvs', 'amgn']",https://twitter.com/JohnCendpts/status/926523854943674368,False,,0,,,,,,,,[],,,,
913397038175412224,913397038175412224,2017-09-28 19:06:38 IST,2017-09-28,19:06:38,+0530,102754598,johncendpts,John Carroll,,AbbVie wins a 5-year free pass on mega-blockbuster Humira in biosim settlement with rival Amgen $AMGN $ABBV +4%  https://t.co/yb4l5653ab,en,[],['https://endpts.com/abbvie-wins-a-5-year-free-pass-on-mega-blockbuster-humira-in-biosim-settlement-with-rival-amgen/'],[],2,10,13,[],"['amgn', 'abbv']",https://twitter.com/JohnCendpts/status/913397038175412224,False,,0,,,,,,,,[],,,,
913373363967549440,913373363967549440,2017-09-28 17:32:34 IST,2017-09-28,17:32:34,+0530,632341632,andybiotech,Andy Biotech,,"$AMGN $ABBV #biosimilar Humira settlement  Amgen expects to launch AMGEVITA in Europe on Oct. 16, 2018,  and AMJEVITA in US on Jan. 31, 2023",en,[],[],[],1,12,11,['biosimilar'],"['amgn', 'abbv']",https://twitter.com/AndyBiotech/status/913373363967549440,False,,0,,,,,,,,[],,,,
907931115104735237,907931115104735237,2017-09-13 17:07:01 IST,2017-09-13,17:07:01,+0530,14886375,stocktwits,Stocktwits,,Amgen hit new all-time highs yesterday. The entire biotech sector needs to watch this. Here's the chart -&gt;  https://t.co/HMtDI18rtU  $AMGN,en,[],['https://stocktwits.com/message/94591004'],[],0,8,16,[],['amgn'],https://twitter.com/Stocktwits/status/907931115104735237,False,,0,,,,,,,,[],,,,
907612932464406528,907612932464406528,2017-09-12 20:02:40 IST,2017-09-12,20:02:40,+0530,37718217,thedomino,Dominic Chu,,"40 S&amp;P 500 RECORD highs in early trade, incl: Microsoft $MSFT Aetna $AET Amgen $AMGN Caterpillar $CAT Waste Mgmt $WM Oracle $ORCL etc  @cnbc",en,"[{'screen_name': 'cnbc', 'name': 'cnbc', 'id': '20402945'}]",[],[],1,1,8,[],"['msft', 'aet', 'amgn', 'cat', 'wm', 'orcl']",https://twitter.com/TheDomino/status/907612932464406528,False,,0,,,,,,,,[],,,,
907303977284489217,907303977284489217,2017-09-11 23:34:59 IST,2017-09-11,23:34:59,+0530,326315947,optionsaction,Options Action,,"Amgen shares hit another all-time high today, and a top technician says there's even more room to run $AMGN  https://t.co/HfpJobyuCG  https://t.co/iQJ0R2LpFW",en,[],['http://cnb.cx/2jjyobU'],['https://pbs.twimg.com/media/DJdkABEUIAAwW16.jpg'],3,4,8,[],['amgn'],https://twitter.com/OptionsAction/status/907303977284489217,False,,1,https://pbs.twimg.com/media/DJdkABEUIAAwW16.jpg,,,,,,,[],,,,
886723788246745088,886723788246745088,2017-07-17 04:36:40 IST,2017-07-17,04:36:40,+0530,102754598,johncendpts,John Carroll,,FDA rejects Amgen‚Äôs osteoporosis drug romo ‚Äî another big plus for rival Radius $AMGN $RDUS $LLY  https://t.co/5VdBUoKOMl,en,[],['https://endpts.com/in-a-setback-fda-rejects-amgens-big-osteoarthritis-play-romo-another-big-plus-for-rival-radius/'],[],1,24,27,[],"['amgn', 'rdus', 'lly']",https://twitter.com/JohnCendpts/status/886723788246745088,False,,0,,,,,,,,[],,,,
874315380533198850,874315380533198850,2017-06-12 22:50:05 IST,2017-06-12,22:50:05,+0530,102754598,johncendpts,John Carroll,,$NVS celebrates -- Amgen loses its bid to delay biosimilars as SCOTUS hands Novartis a victory $AMGN  https://t.co/kCnvlbVA8E,en,[],['https://endpts.com/amgen-loses-its-bid-to-delay-biosimilars-as-scotus-hands-novartis-a-victory/'],[],0,11,5,[],"['nvs', 'amgn']",https://twitter.com/JohnCendpts/status/874315380533198850,False,,0,,,,,,,,[],,,,
867737810228441088,867737810228441088,2017-05-25 19:13:10 IST,2017-05-25,19:13:10,+0530,102754598,johncendpts,John Carroll,,Amgen vet Patrick Baeuerle inspires a $45M round from A-list VCs for a next-gen I/O drug platform $AMGN -trispecific  https://t.co/D6uMoDNsQX,en,[],['https://endpts.com/amgen-vet-patrick-baeuerle-inspires-a-45m-round-from-a-list-vcs-for-a-next-gen-io-drug-platform/'],[],0,1,5,[],['amgn'],https://twitter.com/JohnCendpts/status/867737810228441088,False,,0,,,,,,,,[],,,,
846678922343448577,846678922343448577,2017-03-28 16:32:40 IST,2017-03-28,16:32:40,+0530,102754598,johncendpts,John Carroll,,"Top story Monday: UPDATED: Amgen triggers yet another revamp, moving researchers to two big hubs $AMGN  https://t.co/TukoVKiJ7i",en,[],['https://endpts.com/amgen-triggers-yet-another-revamp-moving-researchers-to-two-big-hubs/'],[],0,4,6,[],['amgn'],https://twitter.com/JohnCendpts/status/846678922343448577,False,,0,,,,,,,,[],,,,
842745068771590145,842745068771590145,2017-03-17 20:00:56 IST,2017-03-17,20:00:56,+0530,102754598,johncendpts,John Carroll,,Amgen's money back guarantee isn't winning over PCSK9 skeptics this morning -- $AMGN $REGN $MDCO - bam!  https://t.co/eIL1Zbc0T6,en,[],['https://endpts.com/heart-attack-while-on-repatha-amgen-will-give-you-your-money-back/'],[],2,14,7,[],"['amgn', 'regn', 'mdco']",https://twitter.com/JohnCendpts/status/842745068771590145,False,,0,,,,,,,,[],,,,
842743421240397825,842743421240397825,2017-03-17 19:54:23 IST,2017-03-17,19:54:23,+0530,14886375,stocktwits,Stocktwits,,There's some serious carnage going on after Amgen's Repatha data release  $AMGN -6% $MDCO -20% $ESPR -21%  CHART:  https://t.co/NplDYYMTWK,en,[],['https://stocktwits.com/michaelbozzello/message/77609428?utm_medium=community-twitter&utm_source=twitter.com&utm_campaign=outboundteam'],[],1,14,13,[],"['amgn', 'mdco', 'espr']",https://twitter.com/Stocktwits/status/842743421240397825,False,,0,,,,,,,,[],,,,
842722324386332672,842722324386332672,2017-03-17 18:30:33 IST,2017-03-17,18:30:33,+0530,102754598,johncendpts,John Carroll,,Heart attack while on Repatha? Amgen will give you your money back $AMGN $REGN $SNY  https://t.co/eIL1Zbc0T6,en,[],['https://endpts.com/heart-attack-while-on-repatha-amgen-will-give-you-your-money-back/'],[],1,3,5,[],"['amgn', 'regn', 'sny']",https://twitter.com/JohnCendpts/status/842722324386332672,False,,0,,,,,,,,[],,,,
827470274484457474,827470274484457474,2017-02-03 16:24:21 IST,2017-02-03,16:24:21,+0530,102754598,johncendpts,John Carroll,,The big news last night - Amgen scores positive PhIII cardio outcomes for its PCSK9 franchise drug Repatha $AMGN  https://t.co/DrswYVoysc,en,[],['https://endpts.com/amgen-scores-positive-cardio-phiii-for-its-pcsk9-franchise-drug-repatha/'],[],0,2,6,[],['amgn'],https://twitter.com/JohnCendpts/status/827470274484457474,False,,0,,,,,,,,[],,,,
827262657405161472,827262657405161472,2017-02-03 02:39:21 IST,2017-02-03,02:39:21,+0530,21778391,cnbcclosingbell,CNBC's Closing Bell,,EARNINGS: Amgen Q4 EPS $2.89 Adj. vs. $2.79 Est.; Q4 Revs. $5.97B vs. $5.74B Est. $AMGN,en,[],[],[],0,10,10,[],['amgn'],https://twitter.com/CNBCClosingBell/status/827262657405161472,False,,0,,,,,,,,[],,,,
781488981846392832,781488981846392832,2016-09-29 19:11:07 IST,2016-09-29,19:11:07,+0530,102754598,johncendpts,John Carroll,,"Amgen beefs up cardio pipeline, adding a $673M RNAi deal with Arrowhead $AMGN $ARWR up 13% #RNAi  https://t.co/dRi2lPvHRm",en,[],['http://endpts.com/amgen-beefs-up-cardio-pipeline-adding-a-673m-rnai-deal-with-arrowhead/'],[],0,9,9,['rnai'],"['amgn', 'arwr']",https://twitter.com/JohnCendpts/status/781488981846392832,False,,0,,,,,,,,[],,,,
781464552198270976,781464552198270976,2016-09-29 17:34:02 IST,2016-09-29,17:34:02,+0530,2334614718,openoutcrier,Open Outcrier,,"$ARWR (+20.0% pre) Amgen $AMGN, Arrowhead Pharma Enter 2 Cardiovascular-Focused License, Collab Agreements - SI    https://t.co/RCTq40DxgS",en,[],['http://ooc.bz/l/6491'],[],0,4,9,[],"['arwr', 'amgn']",https://twitter.com/OpenOutcrier/status/781464552198270976,False,,0,,,,,,,,[],,,,
770771967410593792,770771967410593792,2016-08-31 05:25:31 IST,2016-08-31,05:25:31,+0530,102754598,johncendpts,John Carroll,,#FDA hands Novartis the keys to a $5B Amgen franchise -- but legal fight continues $AMGN $NVS  https://t.co/kqpXdSaWoF,en,[],['http://endpts.com/fda-hands-novartis-the-keys-to-a-9b-amgen-franchise/'],[],0,8,6,['fda'],"['amgn', 'nvs']",https://twitter.com/JohnCendpts/status/770771967410593792,False,,0,,,,,,,,[],,,,
768574799136391172,768574799136391172,2016-08-25 03:54:46 IST,2016-08-25,03:54:46,+0530,102754598,johncendpts,John Carroll,,"According to Amgen, etelcalcetide sailed thru Phase III with nothing but positive data. Rejected. No explanation. $AMGN",en,[],[],[],0,3,5,[],['amgn'],https://twitter.com/JohnCendpts/status/768574799136391172,False,,0,,,,,,,,[],,,,
758401762457899008,758401762457899008,2016-07-28 02:10:45 IST,2016-07-28,02:10:45,+0530,326315947,optionsaction,Options Action,,Big beat for Amgen earnings - why Carter Worth thinks the stock will breakout $AMGN  https://t.co/Sw3dBAAsJH,en,[],['https://amp.twimg.com/v/a3f07226-c019-48de-a6e9-a7158341a125'],[],2,13,26,[],['amgn'],https://twitter.com/OptionsAction/status/758401762457899008,False,,0,,,,,,,,[],,,,
758392028589912064,758392028589912064,2016-07-28 01:32:04 IST,2016-07-28,01:32:04,+0530,44060322,benzinga,Benzinga,,"Amgen Reports Q2 EP S2.84 vs. Est. $2.74, Rev. $5.7B vs. Est. $5.58B $AMGN",ht,[],[],[],0,11,7,[],['amgn'],https://twitter.com/Benzinga/status/758392028589912064,False,,0,,,,,,,,[],,,,
756604486680993792,756604486680993792,2016-07-23 03:09:01 IST,2016-07-23,03:09:01,+0530,326315947,optionsaction,Options Action,,Carter &amp; @Michael_Khouw think Amgen could breakout after earnings next week. Here's how they are trading it $AMGN  https://t.co/JsRWZoWhsC,en,"[{'screen_name': 'michael_khouw', 'name': 'michael c. khouw', 'id': '306850457'}]",[],['https://pbs.twimg.com/media/Cn__ZhlWAAAagmG.jpg'],1,10,14,[],['amgn'],https://twitter.com/OptionsAction/status/756604486680993792,False,,1,https://pbs.twimg.com/media/Cn__ZhlWAAAagmG.jpg,,,,,,,[],,,,
748994615093501952,748994615093501952,2016-07-02 03:10:06 IST,2016-07-02,03:10:06,+0530,326315947,optionsaction,Options Action,,Check out how @Michael_Khouw is making money on Amgen $AMGN  https://t.co/kTFGvQuUwY,en,"[{'screen_name': 'michael_khouw', 'name': 'michael c. khouw', 'id': '306850457'}]",[],['https://pbs.twimg.com/media/CmTsDxFUkAA675S.jpg'],3,12,11,[],['amgn'],https://twitter.com/OptionsAction/status/748994615093501952,False,,1,https://pbs.twimg.com/media/CmTsDxFUkAA675S.jpg,,,,,,,[],,,,
693137665684824064,693137665684824064,2016-01-29 23:54:32 IST,2016-01-29,23:54:32,+0530,1429550540,markmanadvisors,Markman Advisors LLC,,"$AMGN wins right to allege willful infringement in patent case against $SNY &amp; $REGN, accusing Praluent of infringing Amgen's patent.",en,[],[],[],0,7,7,[],"['amgn', 'sny', 'regn']",https://twitter.com/MarkmanAdvisors/status/693137665684824064,False,,0,,,,,,,,[],,,,
637011326490017793,637011326490017793,2015-08-28 02:48:29 IST,2015-08-28,02:48:29,+0530,102754598,johncendpts,John Carroll,,These things are so hard to anticipate: Amgen gets a big win with FDA OK for PCSK9 drug Repatha $AMGN  http://t.co/7cJqbSWAcd,en,[],['http://www.fiercebiotech.com/story/amgen-gets-big-win-fda-ok-pcsk9-drug-repatha/2015-08-27'],[],0,2,5,[],['amgn'],https://twitter.com/JohnCendpts/status/637011326490017793,False,,0,,,,,,,,[],,,,
623464099108810752,623464099108810752,2015-07-21 17:36:39 IST,2015-07-21,17:36:39,+0530,102754598,johncendpts,John Carroll,,"Amgen beats Regeneron, Sanofi to world's first big PCSK9 drug OK  $AMGN $REGN $SNY  http://t.co/VPmwYFwGXr",en,[],['http://www.fiercebiotech.com/story/amgen-beats-regeneron-sanofi-worlds-first-big-pcsk9-drug-ok/2015-07-21'],[],1,14,10,[],"['amgn', 'regn', 'sny']",https://twitter.com/JohnCendpts/status/623464099108810752,False,,0,,,,,,,,[],,,,
602110108022235136,602110108022235136,2015-05-23 19:23:31 IST,2015-05-23,19:23:31,+0530,102754598,johncendpts,John Carroll,,"Suicide stunner prompts Amgen to dump brodalumab for psoriasis, walk away from AstraZeneca $AMGN $AZN   http://t.co/46su0XPbtW",en,[],['http://www.fiercebiotech.com/story/suicide-stunner-prompts-amgen-dump-brodalumab-psoriasis-walk-away-astrazene/2015-05-23'],[],2,6,5,[],"['amgn', 'azn']",https://twitter.com/JohnCendpts/status/602110108022235136,False,,0,,,,,,,,[],,,,
494251330865594368,494251330865594368,2014-07-30 04:11:14 IST,2014-07-30,04:11:14,+0530,16441600,spfeifer22,Stuart Pfeifer,,"Amgen to cut 2,900 jobs, or almost 15% of its workforce, and use the savings to launch new drugs $AMGN  http://t.co/uvxTxvNvrF",en,[],['http://fw.to/izPxk4E'],[],1,21,11,[],['amgn'],https://twitter.com/spfeifer22/status/494251330865594368,False,,0,,,,,,,,[],,,,
